Episodal and paroxysmal disorders

G6_EPIPAROX

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G40-G47 Cause of death: ICD-10 — G40-G47 2 out of 7 registries used, show all original rules.	125833
4. Check minimum number of events None	125833
5. Include endpoints G6_EPLEPSY G6_STATUSEPI G6_MIGRAINE G6_HEADACHE G6_SLEEPAPNO G6_NARCOCATA G6_SLEEPDISOTH	129926
6. Filter based on genotype QC (FinnGen only)	129926

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	G6_EPIPAROX
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_EPLEPSY\|G6_STATUSEPI\|G6_MIGRAINE\|G6_HEADACHE\|G6_SLEEPAPNO\|G6_NARCOCATA\|G6_SLEEPDISOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G4
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G4
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Episodal and paroxysmal disorders based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	923677	467653	450061
Only index persons	834285	431531	402754
Unadjusted period prevalence (%)
Whole population	12.95	13.39	12.57
Only index persons	15.63	15.86	15.37
Median age at first event (years)
Whole population	52.62	52.55	52.67
Only index persons	51.82	51.63	52.03

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	129926	70616	59310
Unadjusted period prevalence (%)	25.02	24.07	26.15
Median age at first event (years)	53.67	51.28	56.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7745: Matched controls
48140

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N03AF02

ATC

oxcarbazepine; oral

79.0

323.0

663

N03AG01

ATC

valproic acid; systemic, rectal

12.2

323.0

846

480

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1283.6

323.0

405

R56.8

ICD-10 Finland

Other and unspecified convulsions

7.9

323.0

979

867

R51.80

ICD-10 Finland

Headache

4.7

323.0

1943

3189

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

17.5

323.0

1513

657

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

353.8

323.0

725

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

323.0

1240

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

13.5

323.0

1542

873

G40.9

ICD-10 Finland

Epilepsy, unspecified

666.3

323.0

685

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

6.5

323.0

1820

2169

G43.9

ICD-10 Finland

Migraine, unspecified

19.9

323.0

1372

516

G47.3

ICD-10 Finland

Sleep apnoea

39.8

323.0

1475

283

G44.2

ICD-10 Finland

Tension-type headache

8.4

323.0

1510

1353

N03AX14

ATC

levetiracetam; systemic

107.1

323.0

424

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

279.7

323

C09CA06

ATC

candesartan; oral

6.5

277.0

848

889

R5140

NOMESCO Finland

Monitoring the use of the aid

13.5

267.0

541

266

N02BE01

ATC

paracetamol; systemic, rectal

2.4

262.6

5099

21531

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

261.4

302

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.7

260.1

884

1061

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

6.2

241.7

771

849

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

7.1

238.2

683

646

N89

ICPC

Migraine

5.5

235.5

819

1006

G43

ICD-10 Finland

Migraine

5.7

234.8

793

939

AA1AD

NOMESCO Finland

CT of head and brain

4.2

234.2

1076

1786

N03AX11

ATC

topiramate; oral

29.9

233.3

367

G43.3

ICD-10 Finland

Complicated migraine

82.5

221.1

294

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

214.3

248

WX780

NOMESCO Finland

Remote monitoring CPAP

+∞

202.1

234

A02BC02

ATC

pantoprazole; systemic

2.2

191.3

2751

9529

WX723

NOMESCO Finland

CPAP therapy

1372.6

188.6

221

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

175.2

203

N05BA09

ATC

clobazam; oral

151.9

169.8

214

C07AB07

ATC

bisoprolol; oral

2.6

162.8

1488

4023

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1176.7

162.6

191

R42

ICD-10 Finland

Dizziness and giddiness

3.1

162.1

1099

2456

N05AH04

ATC

quetiapine; oral

2.5

161.6

1594

4496

C07AA05

ATC

propranolol; systemic

2.7

159.9

1373

3574

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

158.0

2613

9431

N03AX09

ATC

lamotrigine; oral

5.0

156.5

584

767

G43.8

ICD-10 Finland

Other migraine

26.5

150.9

244

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

+∞

143.1

166

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

140.5

163

N02CC07

ATC

frovatriptan; oral

8.1

140.4

365

291

M03BX02

ATC

tizanidine; oral

2.0

138.1

2466

9067

N06AX11

ATC

mirtazapine; oral

2.3

134.5

1642

5105

3007

Kela drug reimbursment

Erenumab and fremanezumab

176.2

133.0

166

N05BA01

ATC

diazepam; systemic, rectal

3.2

131.5

831

1749

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

131.0

152

G40.10

ICD-10 Finland

Simple partial seizures

986.9

129.7

153

N02CC04

ATC

rizatriptan; oral

6.9

128.7

370

345

N03AF01

ATC

carbamazepine; oral, rectal

8.3

128.2

328

254

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

127.3

1411

4170

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

127.2

1698

5483

A03FA01

ATC

metoclopramide; systemic, rectal

3.0

124.1

871

1970

R53

ICD-10 Finland

Malaise and fatigue

2.3

124.1

1442

4356

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

+∞

123.2

143

N02CC06

ATC

eletriptan; oral

9.1

122.9

298

210

M01AE02

ATC

naproxen; oral, rectal

1.8

118.5

4028

18265

N05CD08

ATC

midazolam; nasal, systemic

10.2

115.8

265

167

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.9

111.7

534

893

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

110.9

1329

4050

M79.6

ICD-10 Finland

Pain in limb

2.0

109.7

1706

5830

N02AX02

ATC

tramadol; systemic, rectal

2.1

109.6

1550

5087

N06AX16

ATC

venlafaxine; oral

2.7

107.9

906

2285

Z01.8

ICD-10 Finland

Other specified special examinations

2.4

106.6

1110

3149

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

106.3

1534

5073

M54.5

ICD-10 Finland

Low back pain

2.0

105.3

1705

5908

N02CC05

ATC

almotriptan; oral

7.5

104.8

286

246

N88

ICPC

Epilepsy

139.0

104.1

132

J01DB01

ATC

cefalexin; oral

1.7

102.8

5163

25822

XA800

NOMESCO Finland

Neuropsychological investigation

5.1

101.2

368

465

N03AX12

ATC

gabapentin; oral

3.6

101.1

524

939

N03AX18

ATC

lacosamide; systemic

257.9

100.6

123

N01

ICPC

Headache

1.9

99.9

1884

6902

N02CC03

ATC

zolmitriptan; nasal, oral

6.1

99.7

312

327

R55

ICD-10 Finland

Syncope and collapse

3.0

98.4

683

1523

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

+∞

97.3

113

N06AB10

ATC

escitalopram; oral

2.0

95.8

1552

5351

N05BA04

ATC

oxazepam; oral

2.1

95.8

1332

4312

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

95.1

1850

6832

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

6.9

94.5

270

249

J01AA02

ATC

doxycycline; systemic

1.7

94.5

3168

13941

N02CD01

ATC

erenumab; parenteral

147.6

92.7

117

N03AX16

ATC

pregabalin; oral

2.8

91.3

700

1661

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

91.3

1265

4081

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

5.5

90.9

310

363

G40

ICD-10 Finland

Epilepsy

121.9

90.6

116

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

88.7

1658

6013

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

88.3

4039

19247

M03BC01

ATC

orphenadrine (citrate); systemic

2.4

87.9

923

2612

G47.9

ICD-10 Finland

Sleep disorder, unspecified

9.0

87.5

213

151

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

87.3

1447

5011

R03AC02

ATC

salbutamol; inhalant

1.7

86.7

3295

14900

A02BC05

ATC

esomeprazole; systemic

2.0

86.7

1289

4272

R06.5

ICD-10 Finland

Mouth breathing

3.4

86.4

478

901

H02AB06

ATC

prednisolone; systemic

1.8

86.4

2151

8588

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

86.2

976

2864

G40.89

ICD-10 Finland

Other epilepsy

+∞

86.1

100

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

83.5

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.5

81.6

758

2007

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

80.8

974

2938

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

80.5

1039

3232

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

78.4

5641

29808

M01AB05

ATC

diclofenac; systemic, rectal

1.7

77.7

2491

10650

N06AX21

ATC

duloxetine; oral

3.3

76.6

449

883

P01AB01

ATC

metronidazole; oral, rectal

1.9

75.8

1524

5628

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.7

75.5

386

681

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

+∞

74.8

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

74.1

1249

4323

R51

ICD-10 Finland

Headache

3.0

74.1

495

1070

R06.0

ICD-10 Finland

Dyspnoea

2.1

73.9

1066

3468

S06.0

ICD-10 Finland

Concussion

2.1

73.0

960

3003

G44.0

ICD-10 Finland

Cluster headache syndrome

22.2

73.0

123

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.1

72.6

324

506

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

72.5

1009

3233

M01AG02

ATC

tolfenamic acid; oral, rectal

3.2

72.1

438

883

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

71.8

895

2730

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.9

71.4

498

1107

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

+∞

71.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.1

71.3

454

948

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.5

71.1

388

722

E66.01

ICD-10 Finland

Obesity due to excess calories

3.1

70.3

444

922

M25.5

ICD-10 Finland

Pain in joint

1.9

70.0

1280

4554

XG466

NOMESCO Finland

Sleep oxymetry

14.2

70.0

137

R11

ICD-10 Finland

Nausea and vomiting

2.4

69.9

684

1856

TAB00

NOMESCO Finland

Lumbar puncture

4.1

69.6

312

489

G41.9

ICD-10 Finland

Status epilepticus, unspecified

180.8

69.1

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

68.8

884

2733

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

68.7

898

2796

R4110

NOMESCO Finland

Physiotherapy

2.0

68.7

1086

3659

M01AH05

ATC

etoricoxib; oral

1.7

68.2

1933

7917

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

8.1

66.7

172

135

G44.8

ICD-10 Finland

Other specified headache syndromes

12.2

66.7

139

P06

ICPC

Sleep disturbance

2.2

66.1

769

2270

F51.0

ICD-10 Finland

Nonorganic insomnia

2.1

65.0

861

2692

N02CD03

ATC

fremanezumab; systemic

128.7

64.5

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

2.0

63.9

915

2954

H53.1

ICD-10 Finland

Subjective visual disturbances

3.8

63.5

309

522

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

62.8

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

62.4

1287

4754

L03

ICPC

Low back symptom/complaint

1.8

62.4

1390

5268

E66.8

ICD-10 Finland

Other obesity

5.1

62.1

224

280

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

61.9

831

2611

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

61.6

618

1694

M01AE03

ATC

ketoprofen; systemic, rectal

1.9

61.2

1175

4233

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

60.6

1028

3544

Z71.8

ICD-10 Finland

Other specified counselling

1.7

60.3

1669

6748

R20.2

ICD-10 Finland

Paraesthesia of skin

3.4

60.2

338

642

N05AX08

ATC

risperidone; systemic

2.3

60.1

632

1774

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

59.7

946

3175

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

59.2

976

3325

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

58.9

2564

11654

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

58.5

L01

ICPC

Neck symptom/complaint

2.0

58.0

831

2678

N03AB02

ATC

phenytoin; systemic

17.7

57.7

104

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.2

57.5

718

2180

WX110

NOMESCO Finland

Local anesthesy

1.5

57.3

4678

24360

SPAT1301

SPAT

No procedures

1.6

57.0

2010

8656

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

56.3

752

2352

N05CF01

ATC

zopiclone; oral

1.8

56.3

1177

4356

SPAT1263

SPAT

Sampling

1.5

55.9

2862

13453

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

55.7

1402

5496

M79.1

ICD-10 Finland

Myalgia

2.2

55.5

683

2059

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.0

55.5

874

2920

SPAT1283

SPAT

Restricted health certificate

1.6

55.3

2263

10097

SPAT1240

SPAT

Therapeutic discussion

1.8

55.2

1218

4582

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

55.0

828

2719

R01AD09

ATC

mometasone; nasal

1.5

54.8

2365

10680

SPAT1260

SPAT

Consultation of another employee

1.8

54.6

1051

3778

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

54.3

852

2843

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

+∞

54.2

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

54.2

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

406.7

54.1

N06AB04

ATC

citalopram; systemic

2.0

52.9

836

2796

A04

ICPC

Weakness/tiredness general

1.8

52.6

1168

4396

A02BC01

ATC

omeprazole; systemic

1.8

51.7

1060

3886

N03AX15

ATC

zonisamide; oral

387.7

51.6

SPAT1377

SPAT

Polysomnography

6.6

51.2

150

144

N06AX12

ATC

bupropion; oral

2.3

51.1

567

1629

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

51.0

4779

25273

B01AC07

ATC

dipyridamole; systemic

2.7

50.9

409

991

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

50.5

1604

6685

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

50.1

2908

13943

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

50.1

1030

3775

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

49.8

514

1426

N06AB03

ATC

fluoxetine; oral

2.1

49.4

660

2059

R01AD12

ATC

fluticasone furoate; nasal

1.6

49.3

1759

7548

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

49.2

2861

13710

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.5

49.1

264

485

N05CF02

ATC

zolpidem; oral

2.3

49.1

528

1494

N03AG04

ATC

vigabatrin; oral

+∞

49.0

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

48.7

1911

8389

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

48.6

1359

5466

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

48.4

465

1242

TLC00

NOMESCO Finland

Insertion of intrauterine device

3.5

47.8

257

472

C10AA05

ATC

atorvastatin; oral

2.5

47.6

436

1135

M54.4

ICD-10 Finland

Lumbago with sciatica

2.3

47.5

511

1445

N05AH03

ATC

olanzapine; systemic

2.2

47.3

534

1544

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.4

47.0

474

1298

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

46.5

425

1106

SPAT1310

SPAT

Counselling related to known health issue

1.5

46.5

2293

10581

N03AX22

ATC

perampanel; oral

+∞

46.4

N06AB06

ATC

sertraline; oral

2.0

46.2

733

2448

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.1

45.5

570

1728

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

45.3

560

1689

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

45.1

3510

17711

R74

ICPC

Upper respiratory infection acute

1.5

45.0

2675

12805

T82

ICPC

Obesity

3.7

44.9

222

381

WX402

NOMESCO Finland

General anaesthesia

1.9

44.1

765

2638

N17

ICPC

Vertigo/dizziness

2.1

44.0

580

1798

N05AX12

ATC

aripiprazole; systemic

2.3

43.9

458

1276

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.5

43.5

384

981

L28

ICPC

Limited function/disability (L)

2.3

43.3

454

1266

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

43.1

542

1644

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

43.1

1129

4443

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

42.9

325

759

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

166.1

42.5

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

42.1

R50.9

ICD-10 Finland

Fever, unspecified

1.7

42.1

1018

3912

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.2

41.9

181

275

C07AB02

ATC

metoprolol; systemic

1.9

41.8

732

2531

R06AE07

ATC

cetirizine; oral

1.4

41.5

2783

13578

L17

ICPC

Foot/toe symptom/complaint

1.6

41.5

1362

5689

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

41.2

P03

ICPC

Feeling depressed

1.6

41.1

1170

4706

C10AA01

ATC

simvastatin; oral

2.0

40.7

597

1932

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

40.6

4791

25842

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

40.4

2923

14445

SPAT1254

SPAT

Administration of medicine

1.6

40.2

1380

5824

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

9.4

40.1

R02

ICPC

Shortness of breath/dyspnoea

2.0

39.9

608

1996

N03AX23

ATC

brivaracetam; systemic

299.3

39.6

P29

ICPC

Psychological sympt/compl other

1.9

39.6

695

2404

S18

ICPC

Laceration/cut

1.5

39.4

1716

7650

WX002

NOMESCO Finland

Sedation and analgesia

2.0

39.0

595

1953

R52.9

ICD-10 Finland

Pain, unspecified

2.3

38.5

406

1136

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

65.1

38.4

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.1

38.2

503

1556

A28

ICPC

Limited function/disability NOS

2.4

38.2

368

982

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

38.2

688

2398

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

+∞

37.8

N03AE01

ATC

clonazepam; systemic

3.3

37.6

212

404

J01MA02

ATC

ciprofloxacin; systemic

1.6

37.5

1342

5710

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

37.5

312

771

D01

ICPC

Abdominal pain/cramps general

1.7

37.4

1021

4050

C08CA01

ATC

amlodipine; oral

2.0

37.4

522

1654

R4120

NOMESCO Finland

Occupational therapy

2.7

37.3

287

677

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

37.3

909

3492

J01CA08

ATC

pivmecillinam; oral

1.5

37.1

1631

7271

J01CA04

ATC

amoxicillin; systemic

1.5

37.1

6303

35996

N06BA04

ATC

methylphenidate; oral

2.2

37.0

421

1221

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

36.9

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

36.7

863

3279

G45.3

ICD-10 Finland

Amaurosis fugax

46.5

36.6

P01

ICPC

Feeling anxious/nervous/tense

1.5

36.2

1586

7059

K04.0

ICD-10 Finland

Pulpitis

1.9

36.2

652

2274

XA400

NOMESCO Finland

EEG

11.6

36.2

G40.33

ICD-10 Finland

Juvenile absence epilepsy

+∞

36.1

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

36.1

N06AX26

ATC

vortioxetine; oral

2.1

35.9

456

1389

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.1

35.6

157

244

H03AA01

ATC

levothyroxine sodium; systemic

1.9

35.3

613

2108

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

35.3

227

477

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

35.2

728

2656

E66

ICD-10 Finland

Obesity

3.3

35.1

201

389

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.3

34.7

367

1028

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

10.6

34.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

34.6

1037

4212

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

6.1

34.5

106

110

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

34.4

730

2684

XF404

NOMESCO Finland

Ambulatory ECG

2.5

34.4

306

783

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.5

34.3

178

319

SPAT1097

SPAT

Recording of ECG

2.3

34.3

343

935

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

34.3

1201

5072

D06

ICPC

Abdominal pain localized other

1.9

34.2

562

1894

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

34.1

558

1879

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.6

34.1

287

712

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

34.0

485

1549

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

34.0

325

865

P76

ICPC

Depressive disorder

1.9

33.8

586

2016

N03AD01

ATC

ethosuximide; oral

+∞

33.5

J01FA10

ATC

azithromycin; systemic

1.3

33.4

4357

23491

XF600

NOMESCO Finland

Bloodpressure measurement

2.2

33.3

381

1108

M54.2

ICD-10 Finland

Cervicalgia

2.6

33.2

264

635

P74

ICPC

Anxiety disorder/anxiety state

2.0

33.1

488

1579

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

33.1

315

837

SPAT1153

SPAT

Removal of sutures

1.6

33.1

990

4015

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

5.5

33.0

109

124

R00.2

ICD-10 Finland

Palpitations

2.2

33.0

372

1074

R03DC03

ATC

montelukast; oral

1.7

32.9

786

2996

J01FF01

ATC

clindamycin; systemic

1.6

32.8

1010

4129

D10

ICPC

Vomiting

1.7

32.6

763

2887

D09

ICPC

Nausea

1.8

32.5

671

2447

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

7.1

32.3

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

32.3

285

727

N30.0

ICD-10 Finland

Acute cystitis

1.7

32.2

759

2878

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

32.1

244

570

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

32.1

1008

4139

A03

ICPC

Fever

1.5

32.1

1653

7586

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

2.5

32.0

286

734

C09AA05

ATC

ramipril; oral

2.0

31.8

447

1419

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

31.8

1168

4978

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

+∞

31.8

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

31.8

1025

4234

G04CA02

ATC

tamsulosin; oral

1.7

31.8

755

2872

UJF32

NOMESCO Finland

Coloscopy

1.8

31.7

647

2348

A10BA02

ATC

metformin; oral

1.9

31.6

535

1823

A02BC03

ATC

lansoprazole; oral

1.7

31.5

705

2632

SPAT1050

SPAT

Extensive neurological examination

4.2

31.4

134

202

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.3

31.4

328

913

K30

ICD-10 Finland

Functional dyspepsia

2.1

31.2

386

1161

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

31.2

532

1815

R01AD08

ATC

fluticasone; nasal

1.5

31.2

1285

5622

ZXA05

NOMESCO Finland

Left side

1.7

31.1

756

2894

SPAT1307

SPAT

Psychosocial counselling and guidance

1.6

31.0

1038

4328

WX722

NOMESCO Finland

PEEP

3.8

30.6

145

241

B01AC04

ATC

clopidogrel; oral

2.7

30.6

236

558

C09CA01

ATC

losartan; oral

2.3

30.6

305

829

R07.3

ICD-10 Finland

Other chest pain

2.2

30.4

338

969

J02AC01

ATC

fluconazole; systemic

1.5

30.3

1158

4975

D11

ICPC

Diarrhoea

1.6

30.3

900

3638

SPAT1262

SPAT

Handing over of treatment supplies

2.0

30.3

454

1477

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

4.1

30.2

131

201

R05

ICPC

Cough

1.5

30.1

1345

5981

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

30.0

373

1126

J01EA01

ATC

trimethoprim; systemic

1.5

29.9

1086

4612

F93.89

ICD-10 Finland

Other childhood emotional disorders

2.5

29.9

261

661

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

29.9

334

959

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.2

29.7

171

333

SPAT1312

SPAT

General health counselling

1.4

29.6

2698

13651

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

29.5

350

1033

J35.0

ICD-10 Finland

Chronic tonsillitis

1.9

29.4

521

1804

X58

ICD-10 Finland

Exposure to other specified factors

1.6

29.3

931

3826

SPAT1104

SPAT

Monitoring of emergency patient

2.4

29.3

279

741

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

29.3

271

710

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

29.2

J01FA06

ATC

roxithromycin; oral

1.5

29.2

1429

6473

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.7

29.1

141

239

G45.4

ICD-10 Finland

Transient global amnesia

115.5

29.0

SPAT1229

SPAT

Assessment of need for aid

3.1

29.0

179

367

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

28.8

313

887

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

28.8

681

2583

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

28.7

1357

6100

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.4

28.7

275

734

XA420

NOMESCO Finland

Extensive sleep examination

50.0

28.6

E66.00

ICD-10 Finland

Metabolic syndrome

4.0

28.5

127

200

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.0

28.5

385

1204

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

28.4

810

3238

ZXA10

NOMESCO Finland

Bilateral

1.7

28.4

734

2856

L12

ICPC

Hand/finger symptom/complaint

1.5

28.3

990

4162

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

28.3

1012

4279

XCK00

NOMESCO Finland

Perimetry

2.9

28.2

187

403

ZXA00

NOMESCO Finland

Right side

1.6

28.1

794

3163

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

5.2

28.0

115

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

28.0

727

2831

WX892

NOMESCO Finland

Monitored bed care

2.3

27.6

283

782

M01AC06

ATC

meloxicam; systemic, rectal

1.7

27.5

724

2829

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

27.5

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

+∞

27.5

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

27.5

1927

9313

A01

ICPC

Pain general/multiple sites

2.1

27.5

352

1075

L11

ICPC

Wrist symptom/complaint

1.7

27.4

647

2453

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

27.4

664

2537

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

27.4

475

1632

L02

ICPC

Back symptom/complaint

1.7

27.3

633

2384

N06AX22

ATC

agomelatine; oral

3.0

27.3

174

365

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

27.2

271

737

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

27.2

283

786

SPAT1255

SPAT

Intravenous administration of medicine

2.8

27.1

191

427

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

27.1

423

1399

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

27.0

303

872

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

26.9

582

2147

N02AA05

ATC

oxycodone; systemic

2.2

26.9

307

893

N06BA07

ATC

modafinil; oral

14.5

26.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

26.8

481

1671

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.4

26.8

255

678

S80.0

ICD-10 Finland

Contusion of knee

1.9

26.8

456

1556

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

26.8

330

992

Z00.0

ICD-10 Finland

General medical examination

1.5

26.6

1243

5564

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

26.5

290

825

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

26.5

730

2888

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.3

26.3

146

277

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

26.3

435

1467

WX290

NOMESCO Finland

Other blockade of nerve

1.3

26.3

3422

18156

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

7.2

26.2

J20

ICD-10 Finland

Acute bronchitis

2.0

26.1

359

1129

WZC30

NOMESCO Finland

Teaching

2.0

26.1

358

1125

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

26.0

265

728

N02CD02

ATC

galcanezumab; parenteral

198.5

26.0

EMB10

NOMESCO Finland

Tonsillectomy

1.7

25.9

649

2501

G46.4*I67.9

ICD-10 Finland

Cerebellar stroke syndrome

+∞

25.8

KMAK

NOMESCO Finland

1.3

25.7

2609

13343

M03AX01

ATC

botulinum toxin; parenteral

6.6

25.6

R05

ICD-10 Finland

Cough

1.6

25.6

870

3628

B01AB05

ATC

enoxaparin; parenteral

1.8

25.6

519

1878

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

25.6

284

815

EBA00

NOMESCO Finland

Extraction of tooth

1.3

25.6

2443

12380

H53.4

ICD-10 Finland

Visual field defects

5.7

25.4

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.4

25.4

233

609

L15

ICPC

Knee symptom/complaint

1.5

25.3

1044

4549

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

25.3

2809

14545

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

25.2

467

1641

N04BC05

ATC

pramipexole; oral

3.5

25.0

130

235

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

24.9

339

1062

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

24.8

1109

4914

N02CC02

ATC

naratriptan; oral

8.5

24.7

T90

ICPC

Diabetes non-insulin dependent

2.4

24.6

233

618

SPAT1252

SPAT

Overall medication plan or its review

2.8

24.6

177

403

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

24.6

290

855

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

5.0

24.5

109

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.9

24.4

407

1377

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

24.2

396

1331

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

24.2

448

1572

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.0

24.1

341

1084

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

8.4

24.1

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

24.1

617

2391

214

Kela drug reimbursment

Severe and chronic narcolepsy

+∞

24.0

XA421

NOMESCO Finland

Nocturnal polygraphy

96.7

24.0

Z31.5

ICD-10 Finland

Genetic counselling

2.1

24.0

293

878

SPAT1216

SPAT

Assessment of functional ability

1.8

24.0

425

1471

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

23.9

294

882

R96

ICPC

Asthma

1.9

23.8

381

1270

R52.2

ICD-10 Finland

Other chronic pain

3.3

23.7

131

248

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.9

23.6

161

354

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

12.8

23.6

K02.1

ICD-10 Finland

Caries of dentine

1.3

23.5

3944

21521

ZXC95

NOMESCO Finland

Use of surgical navigator

9.1

23.4

RS222

NOMESCO Finland

4.4

23.4

135

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

23.4

351

1143

R21

ICPC

Throat symptom/complaint

1.3

23.4

2290

11610

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.3

23.3

227

611

TLC02

NOMESCO Finland

Simple extraction of IUD

3.5

23.3

118

209

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.8

23.3

476

1726

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.6

23.1

179

426

H01

ICPC

Ear pain/earache

1.5

23.1

955

4155

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.4

23.1

220

586

R03BA05

ATC

fluticasone; inhalant

1.4

23.0

1140

5152

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

49.9

23.0

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

6.4

22.9

B01AA03

ATC

warfarin; systemic

1.6

22.8

632

2501

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

22.8

208

542

P02

ICPC

Acute stress reaction

1.9

22.8

341

1111

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

22.7

606

2374

R51.81

ICD-10 Finland

Facial pain NOS

4.2

22.6

140

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

22.6

375

1269

J45

ICD-10 Finland

Asthma

1.8

22.5

425

1502

WX704

NOMESCO Finland

Intubation

2.1

22.5

266

785

R5599

NOMESCO Finland

Other rehabilitation service

2.7

22.4

171

404

SPAT1094

SPAT

Continuous Positive Airway Pressure

90.4

22.4

G41.0

ICD-10 Finland

Grand mal status epilepticus

+∞

22.3

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.6

22.3

622

2465

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

22.2

522

1974

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

48.4

22.2

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.9

22.1

355

1186

N76.0

ICD-10 Finland

Acute vaginitis

1.8

22.0

454

1649

K04.08

ICD-10 Finland

Other specified pulpit

1.8

22.0

430

1537

S29

ICPC

Skin symptom/complaint other

1.5

21.9

868

3741

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.1

21.9

273

824

WZA90

NOMESCO Finland

Other doctors statement

1.4

21.9

1646

8000

R03BA02

ATC

budesonide; inhalant

1.5

21.8

915

3995

R06AX27

ATC

desloratadine; oral

1.3

21.7

1677

8182

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

8.9

21.5

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

21.5

663

2694

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

21.5

268

810

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

21.5

D07AC01

ATC

betamethasone; topical

1.4

21.5

1236

5738

N06AX05

ATC

trazodone; oral

3.4

21.4

117

219

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

21.4

238

683

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

21.4

306

979

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.3

21.3

212

578

F32

ICD-10 Finland

Depressive episode

1.8

21.3

388

1355

R29

ICPC

Respiratory symptom/complaint other

1.9

21.3

361

1230

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

21.3

224

628

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

9.7

21.3

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.5

21.3

176

436

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

9.3

21.2

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.1

21.2

132

272

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

21.2

571

2243

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

21.1

697

2881

N05AA02

ATC

levomepromazine; systemic

2.4

21.1

197

520

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

21.1

633

2558

L01AX03

ATC

temozolomide; systemic

17.8

21.0

R4150

NOMESCO Finland

Neuropsychological rehabilitation

7.7

21.0

C03CA01

ATC

furosemide; systemic

1.5

21.0

960

4263

F34.1

ICD-10 Finland

Dysthymia

2.3

20.9

212

584

M54

ICD-10 Finland

Dorsalgia

1.7

20.9

504

1921

R2110

NOMESCO Finland

Giving the first information

2.3

20.8

215

596

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

5.9

20.8

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

20.8

130

270

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

20.8

3082

16454

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

20.7

429

1561

F83

ICD-10 Finland

Mixed specific developmental disorders

2.5

20.7

172

427

A05

ICPC

Feeling ill

1.4

20.7

1031

4658

XF402

NOMESCO Finland

ECG with work load test

2.4

20.6

194

514

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

20.6

800

3431

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.5

20.6

180

458

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

+∞

20.6

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

20.6

356

1220

G43.2

ICD-10 Finland

Status migrainosus

21.2

20.4

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

20.4

260

795

F43.8

ICD-10 Finland

Other reactions to severe stress

2.6

20.4

162

393

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.2

20.3

215

605

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

20.3

445

1647

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.3

20.3

122

L16

ICPC

Ankle symptom/complaint

1.5

20.3

762

3245

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.7

20.1

487

1856

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

20.1

266

824

W10

ICD-10 Finland

Fall on and from stairs and steps

2.2

20.1

215

608

J01DA01

ATC

[U] cefalexin; systemic

1.3

20.1

3386

18340

M79.7

ICD-10 Finland

Fibromyalgia

3.5

20.0

104

189

XQ800

NOMESCO Finland

Prick test

1.7

20.0

506

1954

UDC00

NOMESCO Finland

Ear microscopy

1.7

19.9

435

1608

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.8

19.9

375

1325

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

19.8

149

350

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

19.8

270

848

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

+∞

19.8

282

Kela drug reimbursment

Sodium oxybat

+∞

19.8

N30.9

ICD-10 Finland

Cystitis, unspecified

2.0

19.7

293

951

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

19.6

159

388

R07

ICPC

Sneezing/nasal congestion

1.6

19.6

642

2646

RT150

NOMESCO Finland

5.4

19.6

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.0

19.6

284

912

T90.5

ICD-10 Finland

Sequelae of intracranial injury

4.7

19.5

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

19.3

154

372

M54.6

ICD-10 Finland

Pain in thoracic spine

2.0

19.3

284

917

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

19.3

559

2234

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.2

19.3

217

628

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.7

19.3

142

329

JAH01

NOMESCO Finland

Laparoscopy

2.9

19.3

128

278

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

19.2

283

915

R12

ICD-10 Finland

Heartburn

1.9

19.1

300

996

XKD00

NOMESCO Finland

Uroflowmetry

1.8

19.1

380

1365

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

19.1

318

1076

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

19.0

559

2242

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

77.9

19.0

SPAT1058

SPAT

PEF monitoring instruction

1.8

19.0

359

1270

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

19.0

3501

19115

A29

ICPC

General symptom/complaint other

1.7

18.9

475

1829

G40.35

ICD-10 Finland

Juvenile absence epilepsy

+∞

18.9

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

+∞

18.9

R03AC03

ATC

terbutaline; inhalant

1.5

18.9

641

2667

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

18.8

485

1879

B02AA02

ATC

tranexamic acid; systemic

1.8

18.8

355

1253

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

18.8

325

1115

WX307

NOMESCO Finland

Obstetric epidural analgesia

1.7

18.8

421

1570

7803A

ICD-9 Finland

General symptoms, Convulsions

2.7

18.8

141

330

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

18.7

300

1001

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

2.0

18.7

265

846

U02

ICPC

Urinary frequency/urgency

1.5

18.6

615

2539

R41.0

ICD-10 Finland

Disorientation, unspecified

2.9

18.6

124

270

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

4.8

18.6

G47.8

ICD-10 Finland

Other sleep disorders

4.8

18.6

P85

ICPC

Mental retardation

6.0

18.6

H57.1

ICD-10 Finland

Ocular pain

2.5

18.6

164

421

L86

ICPC

Back syndrome with radiating pain

2.5

18.6

153

379

M02AA07

ATC

piroxicam; topical

1.5

18.5

804

3528

H53.9

ICD-10 Finland

Visual disturbance, unspecified

3.2

18.4

104

202

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

18.4

350

1242

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

18.4

330

1147

UKC02

NOMESCO Finland

Cystoscopy

1.7

18.3

449

1718

F32.8

ICD-10 Finland

Other depressive episodes

2.7

18.3

139

328

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.1

18.3

225

676

K80

ICPC

Cardiac arrhythmia NOS

2.4

18.3

174

465

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.5

18.3

837

3710

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

18.3

240

743

L14

ICPC

Leg/thigh symptom/complaint

1.8

18.2

343

1213

WX725

NOMESCO Finland

Noninvasive ventilation

2.5

18.2

150

371

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

18.1

2944

15808

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.8

18.1

128

290

A02BC04

ATC

rabeprazole; oral

2.2

18.1

206

600

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

9.5

18.1

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

18.0

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

0.7

18.0

462

4263

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.6

18.0

515

2054

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

18.0

179

490

H92.0

ICD-10 Finland

Otalgia

1.8

17.8

332

1170

OAA65

SPAT

1.6

17.8

570

2338

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.6

17.7

474

1856

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.9

17.7

118

257

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

3.2

17.7

191

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

17.7

1253

6007

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

17.7

233

722

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

17.7

196

564

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.3

17.6

172

466

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

17.6

179

494

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.7

17.6

128

295

N07BA03

ATC

varenicline; oral

2.3

17.6

169

455

L08

ICPC

Shoulder symptom/complaint

1.6

17.6

510

2040

P99

ICPC

Psychological disorders other

2.1

17.3

216

655

P20

ICPC

Memory disturbance

2.6

17.3

140

344

N06AB05

ATC

paroxetine; oral

2.3

17.3

167

451

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

17.3

414

1573

E0000UV

ATC

1.3

17.3

2384

12533

R09

ICPC

Sinus symptom/complaint

1.6

17.2

436

1681

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

6.1

17.2

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

17.2

246

789

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

17.2

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.5

17.1

144

361

N07

ICPC

Convulsion/seizure

8.9

17.1

R03BA08

ATC

ciclesonide; inhalant

2.0

17.1

237

750

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

17.1

205

610

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

17.1

279

939

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

2.1

17.1

214

651

J01

ICD-10 Finland

Acute sinusitis

2.0

17.0

237

752

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.1

17.0

101

204

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.6

17.0

132

317

W19

ICD-10 Finland

Unspecified fall

1.5

17.0

560

2312

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

17.0

143

359

R4190

NOMESCO Finland

Nutritional therapy

2.0

17.0

234

740

K07.60

ICD-10 Finland

Snapping jaw

1.9

16.9

267

889

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

16.9

500

2012

K05.22

ICD-10 Finland

Acute pericoronitis

1.4

16.9

854

3860

N06AA09

ATC

amitriptyline; systemic

2.3

16.9

161

431

J35.1

ICD-10 Finland

Hypertrophy of tonsils

1.8

16.8

310

1089

WX872

NOMESCO Finland

Intensive care

3.0

16.8

103

212

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

16.8

543

2231

G45.8

ICD-10 Finland

Other transient cerebral ischaemic attacks and related syndromes

130.8

16.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.0

16.7

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.2

16.7

185

533

R13

ICD-10 Finland

Dysphagia

2.3

16.7

165

449

L05

ICPC

Flank/axilla symptom/complaint

2.0

16.7

232

736

F41.00

ICD-10 Finland

Moderate panic disorder

2.5

16.7

139

348

O99.80

ICD-10 Finland

The fear of childbirth

2.1

16.6

211

646

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

16.6

299

1042

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.0

16.6

213

655

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.1

16.6

200

599

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

16.6

750

3316

F32.1

ICD-10 Finland

Moderate depressive episode

1.6

16.5

455

1797

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

8.7

16.5

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

16.5

494

1992

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

16.5

174

491

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

16.4

2341

12336

C10AA07

ATC

rosuvastatin; oral

2.3

16.4

163

446

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

16.4

170

474

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

16.4

223

701

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

16.4

375

1409

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.3

16.4

160

433

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

4.5

16.3

R40.0

ICD-10 Finland

Somnolence

7.3

16.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

16.3

333

1207

K90

ICPC

Stroke/cerebrovascular accident

6.0

16.3

N07XX04

ATC

sodium oxybate; oral

+∞

16.3

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

16.3

SPAT1234

SPAT

Support of social functional capacity

2.2

16.3

184

534

K08.80

ICD-10 Finland

Toothache NOS

1.7

16.3

385

1457

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

16.2

1578

7914

R33

ICD-10 Finland

Retention of urine

1.9

16.2

274

933

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.8

16.2

Z00.8

ICD-10 Finland

Other general examinations

1.6

16.2

489

1978

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

16.2

333

1211

SPAT1243

SPAT

Psychiatric/psychological examination

1.7

16.1

358

1333

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

16.1

189

559

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.7

16.0

118

274

J01MA12

ATC

levofloxacin; systemic

1.6

16.0

478

1926

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.3

16.0

160

439

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

7.5

16.0

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.8

15.9

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.9

15.9

256

857

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

15.8

487

1978

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.1

15.8

191

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

15.7

197

599

N29

ICPC

Neurological sympt/complt other

3.9

15.7

113

H53.2

ICD-10 Finland

Diplopia

3.0

15.6

206

J01MA14

ATC

moxifloxacin; systemic

2.0

15.6

205

637

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

3.0

15.5

204

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

15.5

377

1439

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

15.5

H26.4

ICD-10 Finland

After-cataract

2.3

15.5

159

442

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

15.5

130

326

R60.0

ICD-10 Finland

Localized oedema

2.0

15.4

220

705

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.2

15.4

171

493

X78

ICD-10 Finland

Intentional self-harm by sharp object

2.9

15.4

101

219

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

15.3

555

2339

A99

ICPC

Disease/condition unspecnature/site

1.7

15.3

320

1168

N05BA12

ATC

alprazolam; oral

1.9

15.3

246

824

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

13.9

15.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

15.3

1454

7265

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

15.3

1011

4783

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.0

15.3

201

625

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.1

15.3

186

560

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.6

15.3

473

1923

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.8

15.3

271

939

ZXC40

NOMESCO Finland

Use of ultrasound

9.6

15.2

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.8

15.2

116

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

24.9

15.2

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.1

15.2

N05AB03

ATC

perphenazine; systemic, rectal

2.4

15.1

140

371

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.2

15.1

166

476

SPAT1360

SPAT

Extensive global examination

1.8

15.1

287

1018

R1260

NOMESCO Finland

Evaluation of communicative skills

3.6

15.1

130

C08DA01

ATC

verapamil; systemic

2.2

15.1

157

441

R10.0

ICD-10 Finland

Acute abdomen

2.2

15.0

161

456

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

18.0

15.0

T74.1

ICD-10 Finland

Physical abuse

2.1

15.0

192

588

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.2

15.0

157

442

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

3.1

15.0

176

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

15.0

198

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

4.3

14.9

Z07

ICPC

Education problem

2.1

14.9

185

561

R31

ICD-10 Finland

Unspecified haematuria

1.7

14.8

302

1094

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

14.8

761

3444

H02AB04

ATC

methylprednisolone; systemic

1.6

14.8

402

1583

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

14.8

160

458

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

14.7

115

278

F92.0

ICD-10 Finland

Depressive conduct disorder

3.0

14.7

193

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

2.6

14.7

114

275

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

6.6

14.7

G41.2

ICD-10 Finland

Complex partial status epilepticus

+∞

14.6

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.9

14.6

213

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.5

14.5

122

307

SPAT1281

SPAT

Other administrative function

1.6

14.5

447

1814

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

9682

32603

1.60

320.32

1.8

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

6132

18302

1.78

316.47

2.4

2.3

21.3

23.3

au/ml

0.65

303

1233

(3007461) Platelets [#/volume] in Blood

71223

347360

1.79

309.33

24.6

17.6

254.4

253.8

e9/l

1.47

70104

337379

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

25225

93852

1.56

307.65

3.3

3.2

31.7

33.8

u/l

3.60

23902

89118

(3018095) Leukocytes [#/volume] in Urine

26069

99572

1.52

307.65

4.0

3.5

73.8

100.5

e6/l

5.25

18990

68149

(3016502) Oxygen saturation in Arterial blood

7785

24674

1.69

307.65

7.7

95.5

95.8

4.04

7493

23688

(3035350) Ketones [Presence] in Urine by Test strip

35804

142918

1.54

307.65

4.0

3.3

0.0

estimate

0.16

7078

26219

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10328

33587

1.67

307.65

5.8

6.2

1.1

mmol/l

0.03

9662

31290

(42870588) Differential panel, method unspecified - Blood

26119

96563

1.59

307.65

5.9

6.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2681

4967

2.83

307.65

1.3

1.4

3.7

mmol/l

0.75

2502

4679

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

63392

282694

1.89

307.65

4.9

3.9

5.9

5.8

mmol/l

88.01

58619

259609

(3048689) Calprotectin [Mass/mass] in Stool

10940

36670

1.62

307.65

2.3

2.5

121.5

135.5

ug/g

3.23

8570

28952

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

60659

262480

1.91

307.65

6.3

4.9

39.8

38.9

mmol/mol

79.29

56936

243446

(3026008) Bacteria identified in Urine by Culture

22068

81547

1.54

307.65

3.3

2.8

—

(3012516) Albumin [Mass/volume] in Urine

20366

72109

1.61

307.65

3.4

3.3

416.9

414.9

mg/l

0.02

13345

45381

(3044290) Cell count panel - Cerebral spinal fluid

2416

4807

2.63

307.65

1.4

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

30941

115155

1.63

307.65

2.5

2.2

2990.5

76.3

nmol/l

0.50

28127

104601

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

28111

110879

1.47

307.65

4.1

3.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

15083

48511

1.74

307.65

4.0

3.4

423.7

560.3

ng/l

1.00

10433

35917

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6722

19749

1.82

307.65

2.5

2.1

6.0

8.0

ug/l

10.90

5824

17041

(3013707) Erythrocyte sedimentation rate by Westergren method

53513

211903

1.99

307.65

4.5

3.7

11.4

mm/h

0.11

50133

196036

(3022096) Basophils/100 leukocytes in Blood

33833

131879

1.57

307.65

6.2

6.1

0.7

0.89

31648

123113

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

33761

118305

1.83

307.65

6.2

5.9

1.2

mmol/l

4.12

30761

107043

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

6729

12661

2.89

307.65

3.4

4.5

1.5

1.7

mmol/l

4.56

4999

9081

(36304419) Bacteria [Presence] in Urine

20025

74828

1.50

307.65

3.3

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

8661

28031

1.66

307.65

1.8

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

54044

218251

1.93

307.65

7.6

7.2

76.6

78.1

u/l

10.22

51134

205269

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

63291

293733

1.62

307.65

4.8

3.8

4.6

4.7

mmol/l

247.80

59522

273837

(40761511) CBC panel - Blood by Automated count

68408

320770

1.92

307.65

15.6

11.2

—

(3006504) Eosinophils/100 leukocytes in Blood

34867

136112

1.58

307.65

6.2

6.1

2.8

0.20

32625

126999

(3029937) Albumin [Presence] in Urine by Test strip

20132

75867

1.49

307.65

4.4

3.6

0.0

estimate

0.34

7028

25855

(3018418) pH of Serum or Plasma

22088

77004

1.66

307.65

3.9

4.1

7.4

0.09

4527

14105

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8819

27547

1.72

307.65

7.3

7.4

5.1

kpa

2.21

8406

26206

(3000850) Epithelial cells [#/volume] in Urine

16345

56681

1.61

307.65

2.7

2.5

5.9

e6/l

0.12

14405

49285

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

30001

93920

2.05

307.65

4.0

3.1

60.2

67.5

ng/l

0.23

19151

58564

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10555

35750

1.60

307.65

2.6

2.5

22.6

23.0

2.37

8957

30657

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

32635

138145

1.37

307.65

4.2

3.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

34362

130966

1.63

307.65

3.2

2.8

110.9

115.9

ug/l

2.53

31990

122175

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

26884

70895

2.46

307.65

2.4

1.9

179.4

234.0

u/l

11.19

25519

66137

(3013650) Neutrophils [#/volume] in Blood by Automated count

41898

167732

1.62

307.65

8.6

9.1

4.1

e9/l

8.16

36939

146161

(1002224) Polysomnography panel

5478

8426

3.51

307.65

1.1

—

(3023368) Bacteria identified in Blood by Culture

19730

70971

1.57

307.65

4.4

4.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

14374

45568

1.76

307.65

1.8

1.7

1171.4

1160.4

nmol/l

0.67

11134

34374

(3015736) pH of Urine

28532

110657

1.51

307.65

3.7

3.1

5.9

5.7

0.33

(3019069) Monocytes/100 leukocytes in Blood

35053

136869

1.58

307.65

6.5

6.3

8.4

8.5

6.65

32967

128380

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

63795

272462

2.24

307.65

5.5

4.3

1.9

2.1

mu/l

1.71

59659

250798

(3003396) Base excess in Arterial blood by calculation

8854

27527

1.73

307.65

7.3

1.1

0.9

mmol/l

6.19

6894

21434

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

29815

106996

1.70

307.65

2.1

1.9

97.9

95.5

pmol/l

12.91

16176

56048

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

38071

142170

1.74

307.65

5.7

6.1

10.7

11.6

umol/l

32.90

35937

134311

(3004789) Transferrin [Mass/volume] in Serum or Plasma

11413

38620

1.60

307.65

2.5

2.4

2.3

g/l

21.47

10552

35640

(3024561) Albumin [Mass/volume] in Serum or Plasma

31789

115825

1.70

307.65

4.7

4.9

36.0

35.7

g/l

21.80

29490

107394

(3009466) Valproate [Moles/volume] in Serum or Plasma

2215

2695

4.31

307.65

4.6

5.8

369.6

373.5

umol/l

0.45

1949

2321

(3022948) Iron [Moles/volume] in Serum or Plasma

12446

41941

1.62

307.65

2.5

2.4

13.4

13.8

umol/l

0.37

11507

38869

(3012095) Magnesium [Moles/volume] in Serum or Plasma

12819

41239

1.71

307.65

3.3

3.7

0.8

mmol/l

5.11

11981

38418

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

19751

68048

1.66

307.65

2.4

2.2

2.9

mg/l

0.86

17031

58010

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

67681

304347

2.26

307.65

16.6

12.1

20.6

24.1

mg/l

140.25

56523

233868

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

64147

298500

1.64

307.65

5.2

4.2

2.7

2.8

mmol/l

139.81

59999

276508

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

36991

131236

1.86

307.65

6.9

6.5

1.2

mmol/l

2.59

31145

110801

(3019198) Lymphocytes [#/volume] in Blood

38502

149012

1.66

307.65

6.1

5.9

2.0

1.9

e9/l

3.35

34376

131329

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

20633

65846

1.83

307.65

3.2

2.8

1203.5

1480.5

ng/l

14.18

17218

56014

(3026782) Osmolality of Urine

15039

52964

1.57

307.65

2.9

2.7

542.6

550.2

mosm/kgh2o

2.97

12960

44953

(3020682) Albumin/Creatinine [Ratio] in Urine

21304

76032

1.61

307.65

4.1

4.0

9.9

9.7

mg/mmol

0.17

13799

48316

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

48472

201823

1.64

307.65

3.5

2.8

48.4

44.3

u/l

18.85

45685

189615

(3002582) Erythrocytes [#/volume] in Urine

22397

83575

1.53

307.65

3.5

3.1

62.3

95.6

e6/l

3.37

17567

63001

(40768797) Stomach Pathology biopsy report

11205

34862

1.76

307.65

1.2

—

(3006315) Basophils [#/volume] in Blood

37629

144408

1.66

307.65

6.0

5.9

0.0

e9/l

2.76

33001

124914

(3013826) Glucose [Moles/volume] in Serum or Plasma

44631

159616

2.05

307.65

5.2

4.4

6.6

6.7

mmol/l

4.45

41995

146731

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1074

160

34.87

307.65

2.6

1.8

54.1

50.0

umol/l

0.68

944

(3009508) Creatinine [Moles/volume] in Urine

22922

81505

1.63

307.65

3.3

3.2

8.0

7.9

mmol/l

0.24

19286

69318

(3001604) Monocytes [#/volume] in Blood

37453

143761

1.66

307.65

6.0

5.9

0.6

e9/l

1.51

32878

124394

(3037467) Urinalysis macro (dipstick) panel - Urine

49179

201684

1.71

307.65

4.8

4.0

—

(3009261) Glucose [Presence] in Urine by Test strip

36054

144934

1.52

307.65

4.0

3.3

0.0

estimate

1.16

7021

26321

(3022217) INR in Platelet poor plasma by Coagulation assay

9824

31567

1.68

307.65

24.9

21.9

1.3

inr

0.04

1563

4430

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

694

261

13.74

307.65

3.0

2.1

28.8

26.4

umol/l

1.99

529

184

(3044889) 12 lead EKG panel

47577

194684

1.67

307.65

4.0

3.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

62800

291450

1.60

307.65

4.7

3.8

1.4

1.5

mmol/l

307.65

58729

270698

(3026493) Urate [Moles/volume] in Serum or Plasma

19589

69451

1.60

307.65

2.7

2.5

3536.0

4393.6

umol/l

2.30

17008

60923

(3036481) Cortisol [Moles/volume] in Serum or Plasma

9140

23004

2.18

307.65

2.1

2.2

359.5

385.0

nmol/l

23.16

8386

21286

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2989

5699

2.76

307.65

1.4

467.5

541.2

mg/l

5.42

2845

5435

(3021960) Folate [Moles/volume] in Serum or Plasma

17309

58390

1.67

307.65

1.6

1.5

20.1

20.3

nmol/l

0.87

15082

50384

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

61765

279362

1.71

307.65

14.4

11.3

85.2

84.8

ml/min/173m2

4.35

52323

225768

(3031040) Bacteria [#/volume] in Urine by Automated count

47440

191425

1.72

307.65

5.1

4.0

1460.4

1400.2

e6/l

0.08

752

2544

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

25041

84632

1.77

307.65

2.7

2.5

56.3

59.0

u/l

5.70

23189

78069

(4010399)

6096

17763

1.82

307.65

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

18921

58313

1.88

307.65

1.9

1.7

1.0

1.3

mg/l

20.44

14069

44093

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

56050

226593

2.02

307.65

4.5

3.8

14.6

14.7

pmol/l

7.87

51828

206391

(3032080) INR in Blood by Coagulation assay

30377

102312

1.87

307.65

9.3

7.8

1.2

inr

0.74

9338

29642

(3015377) Calcium [Moles/volume] in Serum or Plasma

24740

89447

1.62

307.65

3.0

3.4

2.3

2.4

mmol/l

7.52

21723

78466

(3021601) Nitrite [Presence] in Urine by Test strip

35723

143432

1.52

307.65

5.3

4.5

0.0

estimate

0.53

7296

26897

(3021589) Normoblasts [#/volume] in Blood

31405

130634

1.39

307.65

10.1

9.0

0.0

e9/l

0.04

25887

106931

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

13469

44315

1.68

307.65

1.3

1.2

8.5

12.5

u/ml

7.63

5277

17376

(3022313) Gas panel - Capillary blood

5274

8986

3.16

307.65

3.5

5.0

—

(3013512) EKG study

20793

72636

1.64

307.65

4.1

3.5

—

(3033658) Prothrombin time (PT) actual/Normal

19122

69856

1.54

307.65

4.0

3.9

91.5

90.8

3.12

18599

68050

(3019150) Specific gravity of Urine by Refractometry

16656

62094

1.48

307.65

4.4

3.6

1.0

kg/l

0.04

2385

9623

(3007164) IgA [Mass/volume] in Serum or Plasma

16035

58267

1.52

307.65

1.5

1.4

2.3

g/l

2.40

9874

35906

(3018677) aPTT in Platelet poor plasma by Coagulation assay

13909

35923

2.20

307.65

2.1

2.2

29.6

29.9

8.32

13493

34858

(3009343) pH of Capillary blood

6939

13083

2.89

307.65

3.5

4.5

7.4

1.89

765

1847

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2636

5036

2.74

307.65

1.4

1.5

19.4

38.2

e6/l

2.48

2078

3838

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

69260

324580

2.04

307.65

11.6

9.1

28.0

26.1

u/l

38.81

67336

313068

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

18598

66876

1.56

307.65

1.3

1.9

u/ml

9.07

5065

18068

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

61129

280513

1.59

307.65

4.3

3.5

1.4

1.2

mmol/l

277.43

56876

259317

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2639

5040

2.74

307.65

1.5

1499.0

2197.3

e6/l

0.35

2192

4032

(3013115) Eosinophils [#/volume] in Blood

38839

149183

1.68

307.65

6.2

0.2

e9/l

3.64

34582

130931

(3030467) Casts [#/volume] in Urine by Automated count

20426

76253

1.51

307.65

3.3

3.0

0.3

0.4

e6/l

4.29

15699

56354

(3018010) Neutrophils/100 leukocytes in Blood

35430

139656

1.56

307.65

6.1

5.9

56.9

0.24

33259

130967

(3023103) Potassium [Moles/volume] in Serum or Plasma

68463

304357

2.52

307.65

18.6

13.6

4.0

mmol/l

0.49

67136

294768

(3037522) Nuclear Ab [Titer] in Serum

11726

38022

1.69

307.65

1.4

1.3

507.2

553.1

titre

1.65

2236

7660

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

7006

13267

2.88

307.65

3.5

4.5

5.2

5.1

kpa

15.69

6507

12280

(3027801) Oxygen [Partial pressure] in Arterial blood

8813

27532

1.72

307.65

7.3

7.4

12.3

12.8

kpa

9.37

8392

26189

(3019550) Sodium [Moles/volume] in Serum or Plasma

68381

303316

2.53

307.65

18.5

13.5

139.6

mmol/l

6.68

67165

294410

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

14188

47358

1.66

307.65

1.3

33.6

35.4

iu/ml

0.18

4101

15012

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

12739

41194

1.70

307.65

1.9

1.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

17320

65716

1.45

307.65

4.5

4.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

16116

54152

1.67

307.65

1.7

1.6

33911927.6

37111894.5

pmol/l

0.24

13491

45137

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

13020

46729

1.52

307.65

2.7

3.1

2.4

mmol/l

12.90

11225

40810

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8704

28189

1.66

307.65

1.8

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

69287

322461

2.13

307.65

18.4

13.7

76.5

75.6

umol/l

9.36

69273

322258

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

4707

7889

3.19

307.65

3.6

5.2

24.7

24.6

mmol/l

2.59

4406

7298

(3002030) Lymphocytes/100 leukocytes in Blood

35924

141781

1.57

307.65

6.3

6.1

28.5

0.18

33660

132356

(3019060) Gas panel - Arterial blood

5374

15015

1.90

307.65

5.0

4.7

—

(3035941) MCH [Entitic mass]

71242

347706

1.78

302.73

24.4

17.5

30.2

0.44

70593

342505

(3005322) IgE [Units/volume] in Serum or Plasma

5955

17848

1.77

302.44

1.4

1.3

235.6

267.3

u/ml

0.71

5509

16504

(3024731) MCV [Entitic volume]

71247

347749

1.78

302.40

24.5

17.5

90.6

90.5

2.90

70597

342535

(3026361) Erythrocytes [#/volume] in Blood

71251

347791

1.78

301.92

24.5

17.6

4.5

e12/l

6.86

69953

336852

(3010813) Leukocytes [#/volume] in Blood

71263

347881

1.78

301.51

24.6

17.6

6.9

6.7

e9/l

62.63

70001

336924

(3000963) Hemoglobin [Mass/volume] in Blood

71260

347935

1.78

299.39

24.7

17.7

136.0

135.7

g/l

5.24

70609

342761

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

5639

16704

1.79

297.52

1.3

44.6

51.2

au/ml

0.95

174

727

(3044640) Blood type and Crossmatch panel - Blood

22364

90653

1.37

285.20

2.4

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

19951

79557

1.39

279.83

3.5

3.0

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

18040

70768

1.40

278.30

1.7

1.6

1.5

1.3

mmol/l

63.22

15084

60484

(3014576) Chloride [Moles/volume] in Serum or Plasma

9209

31781

1.55

270.52

7.0

7.3

104.5

mmol/l

0.01

8990

31125

(3011397) Hemoglobin [Presence] in Urine by Test strip

16949

66259

1.40

264.27

4.0

3.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

7059

22980

1.63

263.83

8.2

8.1

124.2

120.7

g/l

32.65

6828

22085

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2488

5694

2.28

263.75

3.0

3.3

24.6

24.4

mmol/l

1.52

2172

5062

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

16244

63099

1.41

262.46

1.7

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4954

14775

1.77

253.90

7.4

6.7

24.7

24.5

mmol/l

4.02

4656

13675

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

10602

38303

1.49

249.98

1.9

1.7

1.5

1.4

7.12

9357

34195

(3005719) IgG [Mass/volume] in Serum or Plasma

6388

20573

1.65

248.11

2.6

2.7

10.4

10.6

g/l

5.32

5795

18895

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5634

17620

1.69

244.15

3.1

3.4

4.5

pmol/l

4.52

4996

15807

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5229

16022

1.72

243.87

7.4

7.8

24.8

24.7

mmol/l

1.48

5173

15887

(3012544) pH of Venous blood

7441

24996

1.58

243.60

4.3

4.1

7.4

1.15

114

(3019225) pH of Specimen

7383

24782

1.58

242.41

4.3

4.0

—

(3000494) Fungus identified in Specimen by Culture

8934

31404

1.52

239.08

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3749

10442

1.88

238.20

1.3

1.2

0.7

1.0

u/ml

0.77

349

844

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6166

19894

1.64

237.26

3.2

2.8

173.5

217.5

ng/l

10.95

5529

18062

(3021447) Carbon dioxide [Partial pressure] in Venous blood

7212

24225

1.58

235.68

4.3

4.1

5.9

5.8

kpa

10.84

6983

23484

(3002032) Base excess in Venous blood by calculation

7188

24142

1.58

234.95

4.4

4.2

1.9

1.8

mmol/l

2.43

5913

19524

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

46979

215741

1.30

232.14

3.5

3.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12397

46789

1.43

231.11

2.9

2.7

1.1

1.2

e6/l

0.52

7127

25953

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8980

31899

1.50

227.84

7.6

6.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

9199

32957

1.49

223.65

1.7

1.8

—

(40758558) Short blood count panel - Blood

18039

73078

1.35

218.00

6.5

7.1

—

(40768804) Tissue Pathology biopsy report

27305

117423

1.30

216.22

2.1

2.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5817

18926

1.62

215.56

1.7

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

6262

20748

1.60

215.55

3.7

3.8

1.2

mmol/l

6.16

5498

18006

(3002385) Erythrocyte distribution width [Ratio]

55132

259811

1.32

215.01

19.3

14.8

13.6

4.11

54188

254057

(3010421) pH of Blood

2510

6282

2.08

214.02

4.0

3.6

7.4

2.91

2183

5291

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1186

2063

2.98

212.89

1.5

—

(3027315) Oxygen [Partial pressure] in Blood

2244

5449

2.14

206.32

4.0

3.7

8.8

8.7

kpa

1.75

2191

5316

(3013290) Carbon dioxide [Partial pressure] in Blood

2235

5419

2.15

206.25

4.0

3.7

5.1

5.0

kpa

8.35

2182

5287

(3012501) Base excess in Blood by calculation

2234

5418

2.15

206.02

4.0

3.7

2.4

2.5

mmol/l

1.08

1497

3550

(3022145) Colonoscopy Study observation

8469

30304

1.49

205.75

1.3

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5974

19794

1.59

205.11

2.2

2.6

66.8

66.4

g/l

2.37

5438

18022

(3000492) Spirometry study

7807

27516

1.51

203.85

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1026

1686

3.15

201.68

1.3

1.2

1.9

2.1

mmol/l

3.52

955

1562

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

16897

68567

1.34

198.47

2.4

2.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

5952

19894

1.58

196.62

3.8

3.5

4.7

4.6

kpa

0.09

5738

19208

(1616796) Gas panel - Central venous blood

2183

5346

2.12

196.45

3.6

3.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

8714

31662

1.46

195.30

2.7

2.9

7.1

8.8

umol/l

11.67

7374

27469

(3028626) Oxygen [Partial pressure] in Capillary blood

2418

6178

2.04

195.16

4.0

4.4

8.6

8.5

kpa

0.59

2237

5817

(40761535) Cells panel - Urine sediment

6232

21119

1.56

193.90

3.8

3.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6141

20756

1.56

193.23

2.5

2.0

11.6

12.5

nmol/l

14.20

5421

18556

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11506

44126

1.40

191.70

3.1

2.8

3.2

3.0

e6/l

0.77

6258

23455

(3042936) Bacteria identified in Isolate by Culture

10273

38702

1.42

189.24

2.1

2.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

6585

22719

1.53

188.91

7.0

7.2

1.4

mmol/l

0.20

6291

21877

(3036489) Thrombin time

3438

10084

1.78

184.51

2.1

2.3

21.0

21.6

6.19

2952

8767

(3020779) Urea [Moles/volume] in Serum or Plasma

6586

22835

1.52

184.47

7.8

7.6

9.3

9.5

mmol/l

1.50

6249

21746

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

8615

31571

1.45

183.84

4.7

4.0

31.3

32.6

21.89

6554

21214

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1285

2542

2.62

183.71

1.1

15.8

29.2

au/ml

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5602

18770

1.57

182.49

3.9

4.0

89.6

89.0

ng/l

0.17

4851

16326

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2974

8368

1.85

182.15

2.3

402.5

606.9

ug/l

2.74

2757

7762

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1255

2494

2.60

177.86

1.1

44.0

64.9

au/ml

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

5463

18310

1.57

177.50

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

7969

28953

1.46

177.35

2.7

1.8

1.7

4.93

7021

25646

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

243

15.05

176.30

3.5

3.4

40.8

40.4

umol/l

0.05

212

(3020891) Body temperature

3176

9235

1.80

175.17

4.9

4.8

—

(3025941) Bacteria identified in Stool by Culture

5057

16725

1.59

173.66

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3620

10973

1.72

173.44

2.1

1.9

38.9

39.6

u/l

1.18

3262

9787

(3004588) Protein electrophoresis panel - Serum or Plasma

4831

15818

1.60

172.87

2.0

2.4

—

(36660697) Celiac disease serology panel - Serum

6784

24042

1.49

170.56

1.2

—

(3021901) Oxygen saturation in Capillary blood

1763

4209

2.17

168.63

2.7

3.0

—

(3000991) Gas panel - Venous blood

6346

22247

1.50

167.94

8.5

8.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2907

8330

1.82

167.94

1.7

1.2

g/l

11.75

2769

7936

(3028026) IgM [Mass/volume] in Serum or Plasma

4858

16136

1.58

163.46

1.8

1.9

1.2

1.3

g/l

1.84

4447

14758

(3017181) Myelocytes/100 leukocytes in Blood

6494

23068

1.48

160.87

4.1

4.2

0.9

0.27

1807

6311

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2817

8109

1.81

160.26

1.8

1.7

0.2

g/l

1.72

2683

7696

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2062

5341

2.01

160.11

2.1

1.7

185.3

199.6

pmol/l

6.77

1965

5077

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5986

20946

1.50

159.38

1.2

121.2

150.9

iu/ml

6.94

2248

7895

(3004119) Hemoglobin [Mass/volume] in Venous blood

4541

14961

1.59

157.88

3.9

3.4

131.5

128.6

g/l

13.97

4428

14604

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4022

12901

1.63

155.75

8.9

9.9

24.3

24.2

mmol/l

1.86

3767

12026

(3023410) Appearance of Cerebral spinal fluid

1177

2425

2.51

155.42

1.6

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7276

26598

1.44

155.40

3.6

3.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

6192

21966

1.48

154.03

4.1

4.2

0.1

0.08

1681

5842

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1130

2301

2.54

152.72

1.1

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

2783

8106

1.79

152.26

4.2

4.1

1.4

mmol/l

1.22

2736

7960

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2805

8194

1.78

152.00

1.9

1.6

37.2

43.0

nmol/l

24.43

2733

8025

(3027273) Bicarbonate [Moles/volume] in Venous blood

3698

11683

1.65

151.77

3.8

3.4

25.3

25.2

mmol/l

1.16

3587

11304

(3016018) Differential panel - Cerebral spinal fluid

1222

2598

2.43

151.38

1.4

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

3619

11397

1.66

150.31

3.3

3.1

1.4

1.3

3.43

3600

11337

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4617

15476

1.56

148.91

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2590

7429

1.81

148.87

1.5

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

1035

2043

2.62

148.55

1.2

1.1

35.9

45.0

mg/l

5.97

872

1708

(40767503) Oxygen content in Capillary blood by calculation

1961

5128

1.98

148.26

2.5

2.4

16.9

16.4

5.62

1025

2591

(3002179) Metamyelocytes/100 leukocytes in Blood

5919

20960

1.48

148.24

3.8

4.0

0.6

0.09

1290

4569

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

727

1167

3.21

148.17

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

18877

80362

1.27

146.67

4.7

4.6

3.0

3.4

ug/l

0.70

16870

72383

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4596

15446

1.56

146.47

9.1

9.5

0.7

1.35

4564

15356

(3021387) Prolactin [Units/volume] in Serum or Plasma

3815

12268

1.62

146.00

1.7

1.6

315.2

315.8

mu/l

0.03

3420

11049

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4597

15464

1.56

145.88

9.0

9.4

1.4

2.43

4563

15367

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7041

25868

1.43

145.82

2.6

2.5

34.0

46.1

u/l

2.90

6037

22165

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

1001

1972

2.62

144.21

1.1

236.6

267.9

mg/l

2.91

883

1735

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3524

11174

1.65

142.40

3.3

3.1

0.7

0.76

3379

10731

(3014007) Fractional oxyhemoglobin in Arterial blood

4585

15506

1.55

142.00

9.2

9.5

93.8

94.0

1.77

4565

15450

(3028707) Methadone [Presence] in Urine by Screen method

2224

6167

1.87

141.93

3.0

3.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2782

8295

1.75

140.54

1.9

1.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4387

14740

1.56

139.74

1.7

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

698

1135

3.17

139.51

1.1

—

(3017732) Neutrophils [#/volume] in Blood

5548

19626

1.48

139.24

2.7

4.1

e9/l

0.03

4410

15369

(3025159) Blasts/100 leukocytes in Blood

5816

20777

1.47

139.00

4.1

4.2

0.2

0.11

1414

4954

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

967

1917

2.60

137.66

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4502

15283

1.54

136.94

2.4

2.3

6845.9

6003.8

u/l

0.77

1597

6282

(3023520) Reticulocytes [#/volume] in Blood

5875

21091

1.46

136.86

2.6

2.7

71.7

68.5

e9/l

7.90

4516

15634

(40761536) Microorganisms panel - Urine sediment

6688

24649

1.43

135.55

4.2

3.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

2401

6965

1.79

132.87

4.4

4.3

3.9

mmol/l

0.86

2242

6544

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7952

30349

1.38

131.69

3.9

4.3

236.8

244.5

u/l

3.70

7478

28764

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1161

2577

2.33

131.18

1.3

27.8

30.7

nmol/l

0.17

(3009214) Lutropin [Units/volume] in Serum or Plasma

3073

9601

1.67

131.13

1.4

9.0

9.8

u/l

2.06

2515

7770

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1022

2141

2.47

130.49

2.1

2.5

19.9

20.0

nmol/l

0.12

972

2039

(4027681)

825

1563

2.72

127.80

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

59863

290660

1.26

127.41

17.2

13.0

40.1

40.0

3.64

43497

221748

(3047181) Lactate [Moles/volume] in Blood

2596

7806

1.73

127.18

6.5

5.2

1.3

mmol/l

0.49

2325

6840

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3358

10825

1.62

126.83

4.3

3.8

50.0

47.9

4.97

3324

10696

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1359

3300

2.13

124.57

1.3

1.7

1.0

nmol/l

0.34

1311

3166

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3340

10830

1.61

123.14

2.1

1.9

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1351

3289

2.12

123.05

1.3

0.2

nmol/l

0.23

207

(3028271) Lactate [Moles/volume] in Capillary blood

1502

3819

2.04

122.37

2.0

1.8

1.7

mmol/l

0.57

1465

3726

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3080

9816

1.63

121.61

1.9

1.8

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

4091

13950

1.53

121.49

2.9

2.7

0.3

e6/l

0.05

3977

13536

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3437

11281

1.59

120.47

1.5

14.7

14.4

u/ml

0.04

340

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2425

7304

1.72

118.00

1.4

285.7

273.6

ug/g

1.48

1352

4205

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

640

1099

3.00

117.41

1.3

1.2

65.0

63.8

0.09

137

(3007930) Methemoglobin/Hemoglobin.total in Blood

3068

9862

1.62

117.02

5.9

4.7

0.9

0.92

2892

9200

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3110

10048

1.61

116.20

5.8

4.6

1.8

1.7

2.11

2933

9377

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2469

7518

1.71

115.56

1.3

31.6

37.3

u/ml

0.48

141

474

(3011985) Renin [Units/volume] in Plasma

1308

3230

2.09

114.94

1.5

1.6

59.8

62.6

mu/l

0.18

1180

2901

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

2801

8846

1.65

114.46

1.6

269.5

283.8

titre

0.09

111

354

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

679

1228

2.85

114.22

1.1

4.8

6.0

nmol/l

0.26

135

243

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1230

2978

2.13

113.56

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1835

5141

1.85

113.28

2.8

32.9

34.5

umol/l

1.96

1575

4336

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

746

1434

2.68

112.58

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3181

10428

1.59

111.89

1.6

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3958

13703

1.51

109.23

10.2

9.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4576

16332

1.46

108.77

1.1

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1990

5794

1.78

108.60

2.2

2.1

132.7

129.8

g/l

4.77

1471

4262

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1216

2993

2.10

107.74

1.4

308.2

314.0

pmol/l

0.14

946

2330

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

6624

25339

1.37

106.67

2.3

2.4

0.2

g/l

7.32

6160

23549

(3003327) Ova and parasites identified in Stool by Light microscopy

3072

10122

1.58

105.67

1.7

—

(4306422)

1512

4077

1.92

104.64

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2453

7664

1.66

104.31

1.2

—

(4094501)

2152

6499

1.72

103.61

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2279

7011

1.69

102.64

2.2

2.0

10.9

10.8

mg/l

0.02

2128

6535

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1423

3783

1.95

102.57

1.7

1.6

—

(3052851) Hemolysis interference index of Serum or Plasma

2524

7987

1.64

102.19

3.2

3.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2289

7060

1.68

102.11

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3811

13292

1.49

101.32

2.5

2.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2576

8214

1.63

101.22

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

5709

21508

1.39

100.51

2.6

69.5

67.8

ml/min/173m2

2.05

2363

8130

(42529406) Shigella sp [Presence] in Stool by Culture

2579

8244

1.62

100.34

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

635

1193

2.74

99.96

1.5

1.6

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3807

13325

1.49

99.45

4.7

24.2

24.0

mmol/l

2.91

3412

12109

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2253

6969

1.68

99.42

1.3

9.6

u/ml

0.01

336

1106

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2549

8151

1.62

99.01

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

4124

14691

1.46

98.66

1.1

122.2

214.7

titre

2.28

439

(3022806) Fractional oxyhemoglobin in Capillary blood

1218

3113

2.02

97.86

1.9

1.7

90.2

90.0

0.70

1196

3064

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2877

9510

1.57

97.49

2.2

1.9

1.8

2.4

ug/l

1.34

2529

8378

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

3001

10033

1.55

96.82

2.0

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1855

5494

1.75

95.52

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2212

6883

1.67

95.43

1.3

7.7

6.9

u/ml

0.13

233

725

(3008898) HLA-B27 [Presence]

3126

10593

1.53

94.94

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

684

1375

2.56

94.91

1.1

1.0

1.1

u/l

0.22

290

627

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3472

12048

1.50

94.44

1.1

6.8

13.2

u/ml

0.45

168

(3011288) Drugs identified in Urine by Screen method

3073

10401

1.54

93.82

3.3

3.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1495

4177

1.85

93.01

1.3

1.2

4.0

3.8

u/ml

0.17

661

1900

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2574

8390

1.59

92.44

1.4

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1433

3959

1.87

92.27

1.1

120.3

116.5

4.21

1317

3562

(3035637) Corticotropin [Mass/volume] in Plasma

1231

3241

1.96

91.20

1.5

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1888

5706

1.71

90.58

1.3

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

427

672

3.27

89.86

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4314

15770

1.43

89.79

1.4

1.3

23.7

26.3

iu/l

5.55

3677

13498

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1872

5676

1.71

88.77

1.3

1.2

41.4

45.2

u/ml

0.38

189

547

(3017143) Hepatitis C virus Ab [Presence] in Serum

9587

39606

1.27

88.56

1.7

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1519

4339

1.81

88.15

1.3

1.2

3.4

3.5

u/ml

0.14

514

1510

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1647

4860

1.75

85.85

1.2

125.2

131.6

titre

0.05

102

(3040151) Glucose [Moles/volume] in Capillary blood

1083

2783

2.01

85.78

12.3

6.3

7.5

7.2

mmol/l

0.84

899

2253

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2701

9071

1.55

85.26

2.4

2.7

94.8

91.2

12.13

2501

8467

(3039000) Anion gap in Blood

1785

5415

1.71

84.47

7.7

6.2

11.2

11.3

mmol/l

0.17

1627

4834

(3018572) Chloride [Moles/volume] in Blood

1785

5416

1.71

84.42

7.7

6.2

105.1

105.2

mmol/l

0.17

1627

4835

(3051593) INR in Capillary blood by Coagulation assay

470

819

2.95

84.33

7.2

12.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1569

4597

1.76

83.77

3.1

3.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

3401

12038

1.47

83.71

2.6

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

14704

64136

1.22

82.56

4.2

4.0

22.0

21.9

0.19

6507

29908

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1448

4194

1.78

80.32

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2481

8318

1.55

78.84

2.7

176.3

185.7

5.63

2339

7882

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1787

5534

1.67

78.41

1.2

18.5

13.4

u/ml

0.23

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10158

42876

1.25

77.17

2.2

2.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

783

1880

2.15

73.90

3.4

3.1

29.7

24.6

mu/l

2.59

743

1751

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1791

5640

1.64

73.73

1.3

1.2

4.4

5.6

u/ml

0.28

127

443

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1909

6113

1.62

73.57

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2410

8186

1.53

72.15

3.6

3.3

0.4

0.3

u/ml

4.21

1452

4468

(3023419) Bacteria identified in Sputum by Culture

1025

2758

1.92

71.42

2.6

2.5

—

(3037121) Protein [Mass/volume] in Urine

2655

9237

1.49

70.98

3.0

3.4

0.3

g/l

0.54

1160

4323

(3024980) IgG subclass 4 [Mass/volume] in Serum

1470

4454

1.70

69.86

1.5

1.6

0.7

0.8

g/l

1.44

1069

3405

(3003181) Sodium [Moles/volume] in Urine

1349

3989

1.75

69.82

1.5

65.0

62.5

mmol/l

1.12

1082

3121

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6705

27233

1.29

69.60

2.1

2.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

335

533

3.23

69.50

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2393

8184

1.51

69.40

2.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

334

532

3.23

69.18

1.1

—

(4062490)

1016

2761

1.90

68.79

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2621

9155

1.48

68.70

1.9

2.3

7.3

7.4

g/l

1.09

1919

6871

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

317

490

3.32

68.66

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

330

526

3.22

68.29

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2612

9129

1.48

68.26

1.9

2.3

3.7

3.8

g/l

1.95

1831

6553

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11026

47503

1.22

68.25

2.4

2.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2614

9147

1.48

67.91

1.9

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

331

537

3.17

66.70

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1822

5910

1.59

66.62

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

859

2231

1.98

66.19

1.7

1.4

1.3

1.5

promille

3.24

652

1737

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1808

5865

1.59

66.09

2.3

2.4

133.4

100.7

ug/min

1.58

1085

3533

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3208

11734

1.42

66.06

1.7

1.8

1.5

g/l

0.52

2717

10045

(3045414) Leukocytes [Presence] in Urine

3358

12383

1.41

66.06

1.8

—

(3016879) Cocaine [Presence] in Urine

3871

14643

1.37

65.50

2.5

2.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1003

2762

1.87

65.29

1.4

0.4

g/l

1.23

678

1951

(3028192) IgG subclass 2 [Mass/volume] in Serum

1003

2763

1.87

65.22

1.4

2.9

3.0

g/l

0.75

679

1944

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2468

8607

1.48

65.16

1.9

2.3

3.0

3.1

g/l

6.00

1880

6739

(3003338) MCHC [Mass/volume]

55298

271219

1.16

64.97

20.9

15.2

332.9

332.8

g/l

0.67

54940

268834

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1771

5742

1.59

64.88

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

1003

2768

1.87

64.87

1.4

6.5

6.9

g/l

2.22

671

1952

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1771

5745

1.59

64.74

1.3

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

614

1409

2.24

64.59

1.5

5.6

5.9

u/l

0.38

521

1171

(40768443) Skin Pathology biopsy report

3232

11892

1.41

64.36

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

4106

15773

1.35

62.99

2.4

2.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1308

3955

1.71

62.64

1.3

1.4

—

(4268621)

1021

2870

1.83

62.41

2.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2154

7373

1.51

62.17

1.4

1.5

14.0

14.6

iu/ml

0.06

177

(3048929) Epstein Barr virus Ab [Presence] in Serum

3024

11068

1.42

62.00

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1322

4022

1.70

61.93

1.4

1.3

—

(3028300) Cannabinoids [Presence] in Urine

4133

15934

1.35

61.91

2.5

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5416

21709

1.30

61.81

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

455

927

2.52

61.71

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

511

1108

2.37

60.99

1.6

13.2

5.8

nmol/l

0.32

425

923

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

945

2613

1.86

60.79

1.6

1.7

—

(3027008) Opiates [Presence] in Urine

4115

15899

1.34

60.74

2.4

2.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1511

4788

1.63

60.71

1.4

1.3

21.4

25.3

u/l

4.66

1229

3984

(3022621) pH of Urine by Test strip

4679

18466

1.32

59.70

3.0

2.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

550

1246

2.27

59.63

1.2

16.5

11.6

u/ml

0.31

125

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2437

8629

1.46

59.60

1.1

3.9

5.9

u/ml

1.85

282

1215

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

430

873

2.53

58.76

2.4

2.8

1.1

1.3

ug/l

1.13

392

839

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

526

1177

2.30

58.64

2.6

1.9

146.4

126.0

umol/l

0.69

268

594

(3004616) Nuclear Ab [Presence] in Serum

1082

3174

1.76

57.60

1.3

—

(3034770) Mitochondria Ab [Titer] in Serum

2204

7720

1.48

56.91

1.2

1.3

814.1

989.7

titre

0.68

217

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

1022

2959

1.78

56.85

1.1

96.5

94.9

0.94

966

2754

(3027944) Amphetamines [Presence] in Urine

4027

15674

1.33

56.48

2.3

2.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

442

930

2.44

56.24

1.1

299.1

516.1

ng/l

0.72

221

(3007566) Smooth muscle Ab [Titer] in Serum

2234

7898

1.46

55.04

1.2

1.3

112.8

117.3

titre

0.10

212

730

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2399

8601

1.44

54.96

1.9

2.3

10.1

10.3

g/l

1.26

2001

7199

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2048

7133

1.48

54.37

1.8

1.9

19.3

18.4

iu/l

0.02

703

2719

(3003129) Base excess in Capillary blood by calculation

275

460

3.07

52.97

1.6

1.8

0.5

0.4

mmol/l

0.07

256

428

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

221

319

3.56

52.88

2.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

656

1681

2.01

52.55

1.1

1.2

1.1

ratio

0.45

239

591

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1204

3737

1.66

52.43

1.3

30.9

36.4

u/l

0.70

1065

3245

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

947

2747

1.78

52.39

1.1

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

15379

69641

1.16

52.38

2.0

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

359

709

2.60

51.83

1.2

19.2

21.0

0.15

123

(1761868) Lipid panel - Serum or Plasma

23673

110628

1.14

51.70

2.9

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2194

7831

1.45

51.44

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1366

4401

1.60

51.39

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

4213

16727

1.31

51.26

1.4

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

664

1732

1.97

50.69

11.3

12.2

0.6

mmol/l

2.14

607

1599

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2184

7823

1.44

50.26

2.1

2.4

0.7

0.9

g/l

2.84

1878

6725

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1972

6944

1.47

49.57

2.0

2.3

0.0

g/l

1.89

1779

6361

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

105

6.82

49.17

1.0

—

(4146454)

826

2344

1.81

49.11

2.7

2.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

2079

7420

1.45

48.76

2.8

3.4

50.6

67.9

mg/l

0.98

1649

6051

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2075

7405

1.45

48.69

2.8

3.4

37.6

46.0

mg/l

1.85

1644

6044

(3045424) Erythrocytes [Presence] in Urine

1387

4548

1.57

48.51

1.5

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

243

399

3.13

48.25

1.5

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1097

3402

1.66

47.96

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1067

3285

1.67

47.94

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1065

3283

1.67

47.63

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1064

3281

1.67

47.52

1.4

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1340

4383

1.58

47.37

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2400

8840

1.40

47.36

2.9

2.8

3.5

3.6

g/l

0.42

2268

8437

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2015

7202

1.45

46.90

2.7

3.4

2.9

3.9

ratio

0.36

163

572

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

995

3034

1.69

46.33

2.1

2.0

25.9

27.7

mg/l

0.38

281

801

(3049717) Cytology report of Urine Cyto stain

2469

9181

1.39

46.09

2.5

2.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

686

1873

1.88

45.98

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1066

3321

1.65

45.83

1.4

1.5

—

(3024928) Oxygen saturation in Venous blood

1580

5408

1.51

45.63

4.0

3.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

681

1860

1.88

45.60

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2000

7180

1.44

45.48

1.9

2.2

38.3

37.6

g/l

4.55

1705

6164

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1066

3331

1.65

45.31

1.4

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1167

3738

1.61

45.00

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2200

8052

1.41

45.00

1.2

1.1

—

(3008295) Osmolality of Serum or Plasma

830

2435

1.75

44.29

1.6

1.5

281.1

280.0

mosm/kgh2o

0.62

632

1922

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1900

6791

1.44

44.23

1.4

—

(3019977) pH of Arterial blood

498

1233

2.08

43.78

2.6

2.5

7.4

0.13

152

418

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

822

2414

1.75

43.72

1.7

1.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

484

1187

2.10

43.59

1.1

98.4

95.6

1.08

403

924

(4034850)

2360

8799

1.39

43.36

11.1

8.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1542

5326

1.49

42.66

2.3

2.2

1.0

0.8

nmol/l

16.57

1281

4506

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

10422

46417

1.17

42.61

2.9

2.8

0.7

0.8

ug/l

8.87

6649

29489

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

766

2220

1.78

42.61

1.3

1.6

1.3

nmol/l

7.47

696

2002

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

690

1936

1.83

42.60

1.3

1.1

1.2

u/ml

0.05

297

839

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1018

3196

1.64

42.52

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1095

3505

1.61

42.37

1.5

—

(4198724)

598

1604

1.92

42.29

2.6

2.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

8.55

41.17

1.0

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

491

1242

2.03

40.87

1.1

8.0

11.8

u/ml

1.29

215

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

383

883

2.23

40.11

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

504

1299

1.99

39.91

1.7

1.6

1.3

1.2

nmol/l

0.92

381

1053

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1788

6445

1.43

39.80

2.0

2.3

0.0

g/l

0.76

1601

5884

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

8239

36197

1.19

39.36

1.5

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

1570

5552

1.46

38.66

2.8

3.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

373

867

2.21

38.36

1.2

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1282

4359

1.52

38.25

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1756

6366

1.42

37.90

2.0

2.3

0.0

g/l

0.00

1597

5870

(3039162) Centromere protein B Ab [Units/volume] in Serum

1067

3495

1.57

37.58

1.3

1.2

55.8

48.5

u/ml

0.37

222

(3047007) Chlamydophila sp Ab [Presence] in Serum

1282

4378

1.51

37.49

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2094

7843

1.38

37.43

4.0

4.7

1.5

1.4

mg/l

1.59

1920

7296

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1378

4779

1.49

37.42

1.1

10.2

12.4

au/ml

0.37

336

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

251

490

2.63

37.23

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

162

242

3.44

37.14

1.1

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

382

910

2.16

37.08

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2434

9352

1.34

37.03

1.7

1.6

11.5

5.5

iu/ml

0.37

487

2017

(3042631) Mycobacterium sp identified in Specimen

990

3204

1.59

36.69

2.5

2.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1705

6190

1.42

36.52

1.6

12622.5

13564.8

e6/l

0.30

1255

4489

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2919

11541

1.31

36.42

1.7

1.6

3.9

3.3

mg/l

1.78

2241

7634

(3037756) Immunofixation for Serum or Plasma

1391

4868

1.47

36.14

1.5

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

159

241

3.39

35.73

1.1

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

921

2954

1.60

35.44

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1852

6873

1.39

35.00

1.1

1.2

2.1

u/ml

3.33

817

2889

(3017315) Amylase [Enzymatic activity/volume] in Urine

502

1358

1.90

34.75

1.3

1.2

322.3

321.6

u/l

0.00

465

1273

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1304

4550

1.48

34.40

1.1

1012.5

2789.3

iu/ml

0.36

306

1051

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1045

3480

1.55

34.31

1.5

1.4

—

(3002256) Pathology report gross observation

8445

37585

1.17

34.18

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

631

1848

1.76

34.02

1.6

1.5

67.7

70.8

umol/l

0.64

156

(3020717) Zinc [Moles/volume] in Serum or Plasma

502

1373

1.88

33.65

1.7

1.5

22.5

25.4

umol/l

1.29

481

1311

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

404

1027

2.02

33.31

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

461

1232

1.92

33.09

1.9

2.1

1.9

umol/l

0.07

426

1171

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

143

213

3.44

32.98

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

683

2067

1.70

32.86

1.3

1.2

35.2

58.3

u/ml

1.23

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

164

270

3.12

32.63

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1587

5805

1.41

32.63

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

697

2126

1.69

32.60

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

697

2126

1.69

32.60

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

697

2126

1.69

32.60

1.6

1.7

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

668

2014

1.71

32.58

1.2

79.0

70.3

u/ml

0.25

(3003888) Timothy IgE Ab [Units/volume] in Serum

1679

6204

1.40

32.57

1.1

5.2

6.1

u/ml

1.31

902

3325

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

669

2019

1.70

32.52

1.2

36.0

47.6

u/ml

0.67

146

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1765

6587

1.38

32.28

1.2

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

531

1500

1.82

32.25

1.5

7.3

7.7

ug/l

0.19

481

1356

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

243

504

2.48

32.13

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

643

1926

1.72

32.11

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

11616

53151

1.14

31.95

1.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

644

1935

1.71

31.81

1.2

12.7

10.5

u/ml

0.12

138

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

161

267

3.09

31.69

1.2

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

269

590

2.34

31.65

1.1

5.9

7.2

mg/g

1.68

252

562

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

12465

57335

1.14

31.62

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

1497

5450

1.42

31.62

3.6

2.9

1.5

1.6

mmol/l

0.70

1466

5330

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

642

1931

1.71

31.60

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

603

1783

1.74

31.51

1.4

1.2

5.2

5.3

umol/l

0.26

547

1668

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1675

6222

1.39

31.51

1.3

270.0

253.1

u/ml

1.44

1068

3992

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

486

1345

1.86

31.48

1.9

1.7

136.6

138.3

0.17

459

1266

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1007

3395

1.53

31.33

6.9

6.1

11.4

mg/l

0.01

914

3126

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

530

1511

1.80

31.28

1.2

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

184

334

2.83

31.22

1.0

1.1

76.7

81.6

ug/l

0.77

167

260

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

430

1147

1.93

31.08

1.5

1.4

73.1

72.6

0.27

411

1085

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

277

621

2.29

31.07

1.1

—

(3011412) CD3 cells [#/volume] in Blood

857

2793

1.58

30.94

2.3

2.5

1.3

1.2

e9/l

1.55

524

1687

(3012565) Volume of 24 hour Urine

450

1223

1.89

30.80

1.9

2.3

2021.6

1977.1

0.32

404

1092

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1202

4221

1.47

30.76

3.0

3.1

0.8

nmol/l

0.48

914

3219

(3042517) Benzodiazepines panel - Urine

195

369

2.71

30.75

2.8

3.0

—

(44790049)

901

2978

1.56

30.63

1.6

—

(44790047)

901

2979

1.56

30.59

1.6

—

(44806118)

901

2979

1.56

30.59

1.6

—

(44790048)

901

2980

1.56

30.55

1.6

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

420

1122

1.92

30.24

1.5

1.4

507.6

647.9

mu/l

0.76

401

1060

(3004809) Band form neutrophils/100 leukocytes in Blood

1219

4313

1.46

30.04

3.1

3.3

1.4

1.5

0.32

952

3297

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1591

5907

1.39

30.03

1.1

1.0

1.2

u/ml

0.80

691

2643

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1202

4242

1.46

30.01

1.3

1.4

7.1

7.0

mmol/l

0.68

896

2985

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1092

3782

1.49

29.95

1.1

1.5

g/l

2.35

980

3420

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1237

4408

1.45

29.38

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

372

963

1.98

29.29

1.2

0.3

g/l

0.34

302

762

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

724

2304

1.62

28.87

3.0

2.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

876

2921

1.54

28.69

2.5

2.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1710

6490

1.36

28.22

1.4

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

1395

5125

1.40

28.04

3.7

3.0

7.4

7.6

mmol/l

1.33

1367

5028

(3005570) Glucose [Moles/volume] in Urine

810

2668

1.56

28.01

2.1

1.8

1.9

21.7

mmol/l

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

135

217

3.19

27.95

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

251

566

2.28

27.86

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

942

3214

1.51

27.80

1.6

56.1

56.7

0.16

574

2103

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1563

5866

1.37

27.68

1.1

2.2

2.5

u/ml

0.37

427

1514

(3000034) Microalbumin [Mass/volume] in Urine

709

2270

1.61

27.61

3.0

2.9

66.3

55.9

mg/l

0.32

515

1634

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

347

897

1.99

27.47

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

628

1955

1.65

27.32

1.4

11.7

12.0

umol/l

0.40

595

1858

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5824

25597

1.18

27.15

1.4

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1427

5293

1.39

27.14

1.5

0.4

nmol/l

2.10

1114

4252

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

473

1362

1.78

27.12

1.0

763.6

721.5

ng/l

1.08

316

937

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

471

1356

1.78

27.02

1.0

293.9

338.2

ng/l

2.40

325

973

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

318

802

2.04

26.91

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1318

4830

1.41

26.89

1.6

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

473

1366

1.78

26.86

1.0

40.6

43.7

ng/l

0.64

316

966

(3010144) Erythrocytes [#/volume] in Synovial fluid

724

2355

1.58

26.44

1.4

143515.7

95093.7

e6/l

0.93

497

1620

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1325

4879

1.40

26.31

1.6

1.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

688

2214

1.60

26.28

1.1

60.3

71.3

u/ml

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

193

396

2.50

26.20

2.8

2.7

1.2

mmol/l

0.54

187

371

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

643

2037

1.62

26.16

2.3

2.7

544.1

524.0

e6/l

0.39

543

1667

(3004451) EKG impression Narrative

384

1048

1.88

26.07

1.3

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

614

1927

1.64

25.92

1.5

—

(3017569) Oxygen content in Arterial blood

364

978

1.91

25.88

2.4

2.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

655

2092

1.61

25.81

1.2

1.3

—

39.4

u/ml

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1683

6467

1.34

25.67

1.4

1.5

20.3

20.1

u/ml

0.03

120

(4015189)

241

554

2.23

25.66

2.0

2.4

—

(3014271) Vancomycin [Susceptibility]

409

1148

1.83

25.49

3.0

2.9

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

352

940

1.92

25.48

1.4

14.3

14.9

pmol/l

0.98

302

791

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

652

2087

1.61

25.47

1.2

—

(3016038) Potassium [Moles/volume] in Urine

516

1554

1.71

25.42

1.3

1.4

34.3

35.1

mmol/l

0.28

441

1354

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

135

231

3.00

25.40

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

282

696

2.08

25.28

2.6

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

282

696

2.08

25.28

2.6

2.5

—

(3051611) Lipemic interference index of Serum or Plasma

817

2765

1.52

25.10

3.6

3.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1254

4612

1.40

25.10

1.1

6.3

5.3

u/ml

0.55

552

2002

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

686

2233

1.58

25.02

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

687

2238

1.58

24.97

1.2

—

(44813793)

655

2110

1.60

24.94

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

686

2235

1.58

24.92

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

421

1202

1.80

24.87

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

205

445

2.36

24.81

1.1

0.6

4.0

umol/24h

0.54

100

225

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

858

2943

1.50

24.76

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1448

5468

1.36

24.73

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

338

901

1.93

24.62

1.2

108.8

112.0

1.32

303

806

(43055514) Macroprolactin [Presence] in Serum or Plasma

324

851

1.95

24.61

1.5

1.3

—

(3044927) Protein electrophoresis panel - Urine

676

2202

1.58

24.59

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1326

4946

1.38

24.43

1.1

5.8

4.5

u/ml

0.69

540

2030

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1326

4949

1.38

24.35

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

620

1984

1.61

24.28

2.4

2.7

0.2

e9/l

0.13

540

1672

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

678

2217

1.57

24.27

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

4036

17341

1.20

24.23

1.7

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

678

2218

1.57

24.23

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

677

2214

1.57

24.23

1.2

—

(4024509)

712

2356

1.55

24.22

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

272

675

2.07

24.08

1.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

351

957

1.88

23.95

1.1

93.2

91.2

0.55

158

451

(3011048) Pyruvate [Moles/volume] in Blood

104

157

3.40

23.69

1.4

89.5

80.2

umol/l

1.17

145

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1209

4464

1.39

23.68

1.1

—

(3034426) Prothrombin time (PT)

339

918

1.90

23.61

1.3

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

647

2107

1.58

23.59

2.2

—

(3006270) Folate [Moles/volume] in Blood

668

2194

1.56

23.49

1.2

1.1

362.2

372.9

nmol/l

0.62

568

1863

(3051651) Icteric interference index of Serum or Plasma

517

1594

1.67

23.42

3.9

4.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

378

1067

1.82

23.21

2.1

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

810

2785

1.50

23.15

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1336

5035

1.37

23.13

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1546

5971

1.33

22.83

5.7

5.9

4086.4

1128.7

iu/ml

0.48

210

865

(3021788) Differential panel - Synovial fluid

1275

4783

1.37

22.73

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

478

1457

1.69

22.62

2.3

2.6

875.2

1090.6

u/ml

1.09

469

1445

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

340

938

1.86

22.43

1.1

94.3

91.4

0.61

157

445

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

351

981

1.84

22.26

1.2

110.7

106.9

0.85

309

891

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

513

1601

1.65

22.23

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

209

482

2.23

22.17

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1123

4145

1.39

22.08

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

687

2304

1.53

22.08

1.4

1.3

200.2

70.8

pmol/l

0.73

280

599

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

505

1573

1.65

22.05

1.3

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

255

641

2.04

21.89

1.4

1.2

130.7

130.0

nmol/l

0.02

198

474

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1084

3986

1.40

21.79

1.1

1.0

0.3

0.5

u/ml

1.06

265

868

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

148

292

2.60

21.78

1.3

46.2

56.9

1.46

146

(3016650) Hepatitis A virus Ab [Presence] in Serum

1335

5086

1.35

21.61

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

431

1294

1.71

21.57

2.2

35.2

52.4

umol/l

0.98

146

(1175426) CD3 cells/100 lymphocytes in Blood

678

2287

1.52

21.25

2.2

73.1

72.7

0.27

656

2202

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

582

1899

1.57

21.11

1.1

9.3

7.7

iu/ml

0.55

128

516

(3034988) Calcium [Moles/volume] in Capillary blood

193

440

2.25

21.06

2.8

3.0

1.2

mmol/l

1.24

187

416

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

934

3366

1.43

21.04

1.2

1.1

1.8

2.0

iu/ml

0.13

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

640

2137

1.54

21.01

1.1

285.7

292.1

mg/l

1.33

571

1920

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

714

2449

1.50

20.71

1.5

30.9

31.9

0.29

423

1599

(3008757) Leukocyte morphology finding [Identifier] in Blood

822

2901

1.46

20.70

3.3

3.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

833

2949

1.45

20.65

1.4

11.6

11.9

mmol/l

0.22

184

648

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

686

2335

1.51

20.64

3.7

3.9

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

152

3.24

20.48

1.1

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

887

3185

1.43

20.40

1.5

1.6

30.3

36.0

iu/ml

0.61

152

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

881

3164

1.43

20.25

2.1

2.2

32.8

32.6

0.44

872

3142

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

665

2259

1.51

20.20

2.1

2.2

13.1

13.2

0.06

350

1109

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1542

6061

1.31

20.19

1.4

1.5

108.0

111.6

u/ml

0.50

372

1281

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

350

1009

1.78

20.16

2.0

1.7

151.1

163.6

1.45

333

947

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

393

1175

1.72

20.01

1.8

2.2

27.7

28.5

umol/l

0.94

377

1138

(3010015) Selenium [Moles/volume] in Serum or Plasma

119

219

2.79

19.93

2.5

2.1

1.3

umol/l

0.10

108

198

(3000093) Morphology [Interpretation] in Blood Narrative

736

2565

1.47

19.78

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

359

1051

1.75

19.66

2.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

555

1822

1.56

19.66

2.2

2.4

97.7

97.5

0.06

504

1710

(3001186) Copper [Moles/volume] in Serum or Plasma

252

658

1.97

19.60

1.5

1.3

16.9

umol/l

0.01

225

591

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

196

468

2.15

19.24

1.2

—

(3000330) Specific gravity of Urine by Test strip

3173

13627

1.20

19.13

3.6

3.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

543

1786

1.56

19.10

1.2

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

402

1226

1.68

19.09

1.6

5.1

5.8

mmol/24h

0.49

(3020491) Glucose [Moles/volume] in Blood

615

2082

1.52

19.02

1.6

1.8

6.5

6.6

mmol/l

0.55

452

1577

(3020876) Protein [Mass/time] in 24 hour Urine

612

2071

1.52

18.97

1.9

2.0

1.1

1.0

g/24h

0.03

125

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

365

1086

1.73

18.94

3.6

3.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

394

1200

1.69

18.81

2.0

2.2

38.9

220.2

ug/l

1.29

374

1144

(3035320) C reactive protein [Mass/volume] in Body fluid

602

2034

1.52

18.80

2.7

2.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

193

464

2.13

18.65

1.1

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1028

3855

1.37

18.47

1.6

1.9

3245.3

3634.3

titre

0.08

184

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

132

3.26

18.17

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

146

3.13

18.05

1.1

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1178

4529

1.34

18.05

3.0

3.2

10707.0

4360.3

u/ml

0.30

273

(3028433) Virus identified in Specimen by Culture

306

879

1.79

17.91

1.1

1.2

—

(3010503) CD19 cells [#/volume] in Blood

501

1643

1.57

17.89

2.3

2.7

0.5

0.3

e9/l

0.47

486

1605

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2525

10678

1.22

17.87

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

6350

36448

0.88

17.71

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

418

1320

1.63

17.45

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

418

1321

1.62

17.40

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

418

1321

1.62

17.40

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

418

1321

1.62

17.40

1.8

1.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

731

2614

1.44

17.29

2.9

3.3

57.5

58.2

0.29

473

1630

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

420

1333

1.62

17.19

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

211

543

1.99

17.16

1.2

357.3

335.8

pmol/l

0.10

152

407

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

218

2.63

17.03

1.1

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

852

3141

1.39

17.01

1.1

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

421

1343

1.61

16.90

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

464

1527

1.56

16.38

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1198

4691

1.31

16.23

1.1

2.8

3.0

u/ml

0.21

539

2332

(3018851) Theophylline [Moles/volume] in Serum or Plasma

168

2.84

16.18

1.9

1.7

43.5

46.6

umol/l

0.45

168

(3034274) Bile acid [Moles/volume] in Serum --fasting

1297

5137

1.30

16.16

2.1

2.3

5.7

7.2

umol/l

2.30

937

3791

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1151

4496

1.32

15.88

1.3

—

(3045716) Anion gap in Serum or Plasma

353

1099

1.65

15.64

2.8

2.3

9.1

9.3

mmol/l

0.48

261

804

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2666

11495

1.20

15.44

1.4

1.3

226.1

227.9

miu/ml

0.09

1200

5437

(3024869) Neuronal Ab [Presence] in Serum

164

400

2.10

15.40

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

499

1694

1.51

15.36

1.4

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

777

2874

1.39

15.28

1.2

59.1

70.4

u/l

2.32

505

1980

(3014051) Protein [Presence] in Urine by Test strip

1555

6348

1.26

15.27

2.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

663

2387

1.43

15.19

1.2

200.9

191.2

titre

0.10

101

414

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

374

1191

1.61

15.18

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

374

1191

1.61

15.18

1.4

1.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

661

2382

1.43

15.08

1.2

182.5

182.9

titre

0.00

(3051387) C reactive protein [Mass/volume] in Capillary blood

1511

6166

1.26

14.89

4.0

3.1

25.0

27.3

mg/l

1.50

926

3905

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

502

1719

1.50

14.86

2.7

3.5

113.7

134.7

nmol/l

0.65

491

1687

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

723

2661

1.40

14.66

4.0

4.9

122.3

100.0

u/ml

0.37

217

825

(21491868) Cryoglobulin [Mass/volume] in Serum

307

939

1.68

14.58

1.2

0.3

0.5

g/l

0.60

(3028717) Thiamine [Mass/volume] in Blood

112

238

2.41

14.42

1.1

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

643

2329

1.42

14.29

2.6

0.7

0.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

445

1498

1.53

14.29

1.3

470.0

468.3

titre

0.00

103

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

118

259

2.34

14.20

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

187

495

1.94

14.17

1.8

—

(37021550) Renin [Units/volume] in Plasma --upright

187

495

1.94

14.17

1.3

1.4

110.8

71.9

mu/l

0.47

142

376

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

415

1380

1.54

14.09

2.4

2.3

197.2

202.5

u/l

0.85

410

1371

(3036603) Volume of Urine

506

1756

1.48

14.08

1.5

1.7

1968.8

1942.2

0.11

112

401

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

786

2955

1.37

14.05

2.9

3.3

7.4

7.5

nmol/l

0.02

756

2872

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

369

1195

1.58

14.04

2.2

28.5

29.2

0.42

357

1131

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

114

248

2.36

13.99

1.6

1.7

mg/l

0.14

170

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

399

1318

1.55

13.95

1.1

88.1

86.3

u/l

0.13

326

1045

(40761539) Cells [Type] in Urine sediment by Light microscopy

229

652

1.80

13.94

1.3

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1330

5390

1.27

13.92

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.77

13.88

1.1

1.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

4.77

13.88

1.9

1.4

155.3

366.2

nmol/l

1.20

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

151

2.78

13.88

1.2

33.2

17.7

0.91

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

599

2154

1.43

13.87

2.3

2.7

797.1

672.7

e6/l

3.29

253

794

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

382

1251

1.57

13.87

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

485

1674

1.49

13.87

1.3

1.4

5.7

5.5

mmol/l

2.52

458

1586

(3006245) CD3-CD19+ cells/100 cells in Blood

378

1235

1.57

13.86

2.3

2.4

11.4

11.1

0.16

357

1154

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

234

673

1.78

13.79

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1329

5392

1.27

13.79

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

305

946

1.65

13.78

2.5

2.2

—

(3044941) Cell count panel - Synovial fluid

1037

4075

1.31

13.78

1.3

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

514

1798

1.47

13.76

1.8

1.7

—

(3003694) ABO and Rh group [Type] in Blood

18824

91423

1.07

13.70

1.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

496

1725

1.48

13.67

1.6

1.5

26.1

25.0

u/ml

0.16

349

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

397

1318

1.55

13.60

1.1

26.0

25.0

u/l

0.09

312

1006

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.70

13.51

1.3

1.4

554.7

472.1

nmol/l

0.37

(21494890) Protein electrophoresis panel - 24 hour Urine

662

2440

1.39

13.37

1.8

2.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

417

1408

1.52

13.25

1.1

1589.5

1478.6

miu/ml

1.11

417

1408

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

119

271

2.25

13.24

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

428

1457

1.51

13.10

1.3

58.9

80.0

titre

0.56

118

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

155

2.68

12.84

1.4

1.5

32.8

37.1

0.35

101

(3028679) Herpes simplex virus Ab [Presence] in Serum

497

1752

1.46

12.84

1.2

—

(3019174) dRVVT (LA screen)

108

239

2.32

12.82

1.1

1.2

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

3.32

12.78

1.1

0.1

0.5

mg/l

0.48

(3045683) HLA typing for celiac disease panel - Blood or Tissue

538

1934

1.43

12.54

1.0

—

(3018133) Calcium [Moles/volume] in Urine

184

506

1.87

12.54

2.2

2.4

2.8

2.6

mmol/l

0.61

163

457

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

2.6

1.8

mg/l

0.70

183

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

3.0

2.7

mg/l

0.14

168

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

2.7

mg/l

0.01

172

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

1.7

1.9

mg/l

0.22

156

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

1.9

2.2

mg/l

0.20

160

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

0.9

mg/l

0.06

167

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

1.8

1.9

mg/l

0.04

172

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

3.9

mg/l

0.03

154

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

109

245

2.28

12.51

1.6

1.3

1.1

mg/l

0.15

161

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

292

922

1.63

12.38

2.4

2.1

71.0

62.4

ug/l

0.72

283

904

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1551

6489

1.23

12.32

1.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

191

537

1.82

12.18

1.3

1.2

—

(44806071)

138

347

2.04

12.11

1.1

—

(3024263) Appearance of Synovial fluid

385

1306

1.51

12.04

1.7

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1497

9320

0.82

11.83

1.4

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

101

226

2.29

11.74

1.1

1.8

3.3

umol/24h

0.47

101

226

(3014148) Varicella zoster virus Ab [Titer] in Serum

1084

4379

1.27

11.74

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

148

389

1.95

11.55

1.7

1.9

55.5

45.3

pmol/l

0.43

119

336

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

494

1778

1.43

11.50

1.5

1.4

12.5

12.6

u/l

0.10

472

1718

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

222

2.29

11.47

1.3

—

(3005033) Fetal Nuchal fold Thickness US

1499

9299

0.82

11.43

1.4

1.5

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.82

11.29

2.7

1.6

2.7

2.2

mu/l

0.17

(4211845)

421

1477

1.46

11.22

2.9

2.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

302

987

1.57

11.18

1.1

1.0

9.1

12.4

u/ml

0.64

120

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

263

831

1.62

11.18

2.6

3.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

136

351

1.99

11.18

1.2

1.3

—

(3022689) Creatine [Moles/volume] in Urine

236

725

1.67

11.17

1.5

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

369

1262

1.50

11.15

1.5

4.1

0.03

310

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

120

2.78

11.05

1.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

311

1027

1.55

11.02

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

311

1028

1.55

10.98

2.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

219

663

1.69

10.95

1.4

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

5648

31793

0.90

10.94

1.7

1.6

—

(3006576) Bicarbonate [Moles/volume] in Blood

275

884

1.60

10.93

6.5

6.2

24.8

24.9

mmol/l

0.13

254

797

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

314

1042

1.55

10.90

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1547

9510

0.83

10.74

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

310

1030

1.54

10.71

1.1

2.1

17.5

u/ml

1.00

181

616

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

658

2516

1.34

10.70

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

3776

21694

0.89

10.60

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

201

600

1.72

10.59

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

201

600

1.72

10.59

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

201

600

1.72

10.59

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

201

600

1.72

10.59

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

563

2108

1.37

10.48

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

205

619

1.70

10.38

1.1

1.2

82.5

87.6

0.67

163

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

307

1028

1.53

10.27

1.0

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

389

1370

1.46

10.22

1.2

1.1

4.2

4.1

iu/ml

0.03

107

(3006462) Nitrate [Presence] in Urine

384

1349

1.46

10.22

3.0

2.9

—

(3000060) B lymphocytes [#/volume] in Blood

290

960

1.55

10.22

2.3

236.6

687.3

e6/l

1.04

176

515

(3029075) Extractable nuclear Ab panel - Serum

264

855

1.58

10.21

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3829

21919

0.89

10.11

1.5

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

212

652

1.67

10.06

1.3

105.9

106.5

0.08

201

616

(3000012) Reticulocyte production index

396

1405

1.45

10.03

1.4

1.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

138

374

1.89

9.94

2.8

2.3

1.3

1.4

mmol/l

0.38

268

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

137

2.54

9.89

1.4

1.5

15.0

11.6

0.44

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

458

1674

1.40

9.87

1.5

1.6

5.6

6.2

u/l

0.26

204

842

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

158

452

1.79

9.65

2.5

2.4

7.8

7.3

mmol/l

0.48

106

264

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

115

2.67

9.60

1.4

1.3

1.4

0.10

(3001964) Herpes simplex virus Ag [Presence] in Specimen

262

861

1.56

9.57

1.6

1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

161

465

1.78

9.54

5.2

6.1

69.1

70.4

0.25

122

366

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

142

395

1.84

9.49

2.3

2.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

294

995

1.52

9.42

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

201

622

1.66

9.36

1.2

1.1

70.9

75.9

0.61

158

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

155

447

1.78

9.25

1.6

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

421

1535

1.41

9.24

1.8

2.5

2.4

u/field

0.13

322

1091

(3017704) Immunofixation for Urine

358

1268

1.45

9.20

1.5

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

1577

6808

1.19

9.19

4.4

3.8

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

125

337

1.90

9.19

1.0

0.2

u/ml

0.09

212

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

514

1945

1.36

9.04

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3368

15400

1.13

8.98

2.7

3.3

48.2

50.5

u/ml

0.09

3234

14902

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

516

1956

1.35

8.98

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1922

11416

0.86

8.91

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1927

11443

0.86

8.90

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1926

11437

0.86

8.90

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

128

352

1.86

8.89

1.0

1.1

1.0

3.2

u/ml

0.62

195

(3013166) Neutrophils/100 leukocytes in Synovial fluid

237

775

1.57

8.88

1.3

1.4

54.6

54.8

0.02

191

679

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.45

8.86

1.7

1.4

214.2

266.2

nmol/l

0.25

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1917

11383

0.86

8.85

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

127

349

1.87

8.84

1.1

0.1

0.9

u/ml

1.68

192

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.25

8.83

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

529

2025

1.34

8.66

13.4

13.5

784.6

1591.7

nmol/l

0.83

507

1960

(3042111) Morphology [Interpretation] in Bone marrow Narrative

991

4114

1.24

8.63

1.6

1.7

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

103

267

1.98

8.49

1.5

1.6

120.8

107.3

ug/l

0.52

219

(40762365) Oxygen content in Arterial blood by calculation

134

380

1.81

8.49

2.7

3.0

15.1

14.6

ml/dl

0.98

125

352

(3044009) aPTT.lupus sensitive (LA screen)

100

257

1.99

8.44

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

162

487

1.71

8.44

1.8

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

137

394

1.78

8.30

1.5

1.4

375898.8

141386.5

nmol/l

0.56

112

319

(3052592) Norovirus Ag [Presence] in Stool

162

490

1.70

8.27

1.4

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

110

295

1.91

8.26

1.2

1.1

—

(3051339) Copper [Moles/volume] in Blood

125

2.46

8.25

1.1

1.4

16.8

16.4

umol/l

0.24

107

(3016228) CD19 cells/100 cells in Blood

318

1126

1.45

8.24

2.1

9.9

8.4

1.01

308

1104

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

277

955

1.49

8.21

1.9

1.7

62733.5

17064.9

u/ml

0.56

119

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

142

2.35

8.11

1.4

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1126

4772

1.21

8.06

2.0

2.2

6.6

6.4

titre

0.02

147

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

548

2133

1.32

8.04

18.4

18.9

1403.9

2586.2

nmol/l

0.79

522

2041

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

139

406

1.76

8.02

1.1

0.2

0.3

u/ml

0.21

251

(3001556) Androgen free Index in Serum or Plasma

127

361

1.80

8.01

1.4

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

225

2.03

7.88

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

201

2.09

7.86

1.0

0.4

2.3

u/ml

1.52

156

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

135

2.35

7.81

1.1

4.3

2.6

u/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

217

718

1.55

7.80

1.2

40.7

40.0

g/l

0.23

108

406

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

345

1254

1.41

7.80

3.4

3.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

310

1106

1.44

7.76

2.0

2.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

258

890

1.49

7.67

3.8

3.5

52.2

0.01

252

853

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

114

318

1.84

7.65

1.1

1.0

0.5

u/ml

0.06

182

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

176

2.16

7.65

1.0

0.3

0.7

u/ml

0.98

164

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

281

987

1.46

7.64

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

207

2.06

7.63

1.3

10.1

15.2

pmol/l

0.88

176

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.20

7.59

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

117

330

1.82

7.59

1.4

1.3

61.8

171.4

titre

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

187

2.11

7.57

1.1

2.4

2.7

u/ml

—

(3036180) Methadone [Presence] in Urine

3.13

7.54

2.6

2.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

197

643

1.57

7.53

1.1

1.2

2.2

8.2

u/ml

2.95

137

464

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

2088

12176

0.88

7.52

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

336

1225

1.41

7.49

6.4

4.0

3292.5

2556.4

mg/l

0.20

232

888

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

171

2.16

7.48

1.1

8.6

11.2

u/l

0.59

171

(3007463) Buprenorphine [Presence] in Urine

138

2.30

7.47

8.1

8.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

517

2020

1.31

7.43

1.8

1.9

3.6

3.8

mg/l

0.20

488

1921

(3001686) Cold agglutinin [Titer] in Serum or Plasma

145

439

1.69

7.43

1.3

1.4

66.9

178.2

titre

1.00

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

238

1.96

7.39

1.3

1.2

14.3

17.0

nmol/l

0.83

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

250

864

1.48

7.38

2.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

178

570

1.60

7.37

1.4

1.5

5.5

5.7

nmol/l

0.27

169

543

(3008116) Ketones [Moles/volume] in Urine by Test strip

171

544

1.61

7.28

1.4

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

180

2.11

7.27

1.0

1.1

19.8

u/ml

0.00

149

(3016750) Collection duration of Urine

400

1511

1.36

7.23

2.2

506.3

500.8

min

0.54

297

1142

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.76

7.20

1.0

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

213

716

1.53

7.18

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

550

2179

1.30

7.16

1.1

—

(4035726)

5178

24495

1.09

7.15

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

737

4670

0.81

7.13

3.4

3.6

31.5

38.7

u/ml

0.74

716

4490

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

559

2230

1.29

6.93

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2378

10824

1.13

6.92

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

663

2703

1.26

6.89

2.2

2.3

43.9

41.0

0.98

323

(3004775) Volume in Urine collected for unspecified duration

520

2058

1.30

6.85

2.2

2.3

665.4

671.9

0.13

355

1427

(3020123) Porphyrins [Interpretation] in Serum or Plasma

158

2.14

6.77

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

556

2225

1.28

6.74

2.0

1.8

2.5

u/field

1.92

277

965

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

218

1.95

6.70

1.1

8.3

8.9

u/ml

0.07

141

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.88

6.67

1.0

0.1

u/ml

0.11

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1059

4552

1.19

6.63

3.0

2.3

13.1

0.27

1049

4492

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

160

2.11

6.58

1.4

1.3

23.9

15.0

pmol/l

0.97

137

(3011897) Casein IgE Ab [Units/volume] in Serum

182

604

1.55

6.54

1.1

1.3

5.6

9.1

u/ml

0.27

151

(3020650) Glucose [Presence] in Urine

221

765

1.48

6.54

1.5

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

143

449

1.63

6.47

1.3

1.4

680.9

105.0

ng/l

0.46

285

(3017509) Phencyclidine [Presence] in Urine

132

406

1.67

6.45

1.9

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

183

611

1.54

6.42

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

121

364

1.70

6.41

1.0

1.1

2.0

5.4

u/ml

1.05

289

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

216

748

1.48

6.39

1.7

1.6

9.5

8.8

ug/l

1.47

216

748

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

183

612

1.53

6.37

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1674

7494

1.15

6.32

1.2

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

142

448

1.63

6.31

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

212

736

1.48

6.21

1.0

1.1

1.2

2.0

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

182

612

1.52

6.20

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

120

364

1.69

6.19

1.0

1.1

1.4

3.5

u/ml

1.51

288

(3020874) Milk IgE Ab [Units/volume] in Serum

548

2216

1.27

6.16

1.0

1.1

2.4

3.1

u/ml

0.17

168

720

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

119

361

1.69

6.14

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

156

508

1.57

6.12

1.2

74.7

43.8

mg/l

0.28

104

376

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

383

1481

1.33

6.03

1.8

1.6

3365198.7

1485180.0

iu/ml

1.19

106

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

264

1.81

6.02

2.0

2.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

202

701

1.48

5.95

1.2

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

101

296

1.75

5.90

1.6

1.2

1.8

2.4

mmol/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

154

2.06

5.86

1.2

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

244

1.83

5.86

1.3

1.2

44.6

47.0

mg/l

0.24

(3043410) Blood group antigens tested for on Red Blood Cells

219

776

1.45

5.82

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1419

8332

0.87

5.77

1.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2702

12535

1.11

5.70

2.0

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

325

2208

0.75

5.69

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

228

1.84

5.68

1.0

8.1

2.4

u/ml

1.10

(3013466) aPTT in Blood by Coagulation assay

174

1.97

5.65

1.1

35.8

37.1

0.82

150

(3015076) Soybean IgE Ab [Units/volume] in Serum

482

1941

1.27

5.65

1.0

1.1

0.5

0.8

u/ml

0.51

290

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

175

597

1.50

5.63

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

897

5437

0.84

5.55

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

131

420

1.60

5.53

1.5

1.6

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

425

1691

1.29

5.49

1.2

90.7

95.6

u/l

0.38

361

1494

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.79

5.48

1.2

1.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

195

1.89

5.42

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1887

10831

0.89

5.39

1.5

1.6

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.56

5.34

1.1

—

mmol/l

—

(3015183) Erythrocyte sedimentation rate

404

1604

1.29

5.32

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

298

1133

1.35

5.31

1.8

2.1

8.7

9.5

mg/l

1.54

239

910

(3014599) Egg white IgE Ab [Units/volume] in Serum

530

2176

1.25

5.31

1.1

2.3

5.9

u/ml

1.12

144

621

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

273

1024

1.37

5.30

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

219

1.83

5.28

1.1

1.0

0.5

1.0

u/ml

0.32

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

238

1.79

5.26

1.1

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.87

5.21

1.4

117.2

135.4

nmol/l

0.27

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1530

6909

1.14

5.17

1.3

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

169

584

1.48

5.15

1.5

0.4

ug/l

0.01

115

385

(3016031) Almond IgE Ab [Units/volume] in Serum

236

1.78

5.14

1.0

1.1

0.4

0.9

u/ml

1.68

152

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

411

1644

1.28

5.13

1.2

25.5

25.0

u/l

0.06

344

1433

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

155

527

1.51

5.11

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

166

573

1.49

5.09

1.5

0.2

nmol/l

0.31

120

418

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

146

2.00

5.04

1.1

52.6

103.5

u/l

0.58

115

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

111

351

1.62

4.99

1.1

1.0

—

(3024316) Viscosity of Plasma

116

2.12

4.92

1.3

1.9

1.4

1.7

mpas

1.76

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

315

1226

1.32

4.84

2.1

82.1

99.7

ug/min

0.22

286

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

242

906

1.37

4.81

1.7

104.4

149.1

au/ml

0.89

122

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.24

4.76

2.0

2.1

—

(40759632) Porphyrins [Mass/mass] in Stool

3.79

4.70

1.0

1.1

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

136

2.00

4.69

1.3

1.7

1.6

mg/l

0.37

116

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

187

674

1.42

4.64

1.2

1.3

36.9

38.8

0.27

116

463

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

6.83

4.61

1.1

1.0

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.34

4.61

1.0

1.1

127.8

271.4

pmol/l

1.77

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

137

465

1.51

4.60

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

127

2.02

4.55

1.4

1.5

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

156

1.91

4.52

1.3

1.1

1.2

u/field

0.32

105

(3049233) Organic acids panel - Urine

2.48

4.50

1.3

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

139

1036

0.69

4.46

6.0

6.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2368

11064

1.10

4.43

1.3

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.07

4.39

1.1

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

136

1.96

4.39

1.4

2.0

0.7

umol/l

0.02

113

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

193

708

1.40

4.37

1.8

1.9

24.6

44.4

u/l

1.68

182

631

(40761995) Spermatozoa Progressive [#/volume] in Semen

140

1036

0.69

4.33

3.0

3.2

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

119

398

1.53

4.30

4.8

5.2

42.4

45.4

ug/min

0.18

314

(3037692) Legionella sp identified in Specimen by Organism specific culture

234

889

1.35

4.29

1.6

1.4

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

103

2.09

4.21

1.3

1.5

—

(3009015) Lactate [Moles/volume] in Synovial fluid

252

1.67

4.18

1.3

1.2

5.3

6.5

mmol/l

1.21

127

(3050129) First trimester maternal screen panel - Serum or Plasma

2592

14441

0.92

4.18

1.5

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

551

2337

1.21

4.17

1.3

6.4

6.2

mmol/l

0.79

498

2156

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

468

1953

1.23

4.16

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

410

1687

1.25

4.14

2.7

41.7

38.5

1.72

164

525

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.18

4.10

1.0

1.1

0.2

g/l

0.04

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

416

1718

1.24

4.08

6.0

6.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

105

346

1.56

4.07

2.4

0.6

u/field

0.42

105

346

(3036071) Salmonella sp Ab [Titer] in Serum

257

999

1.32

4.07

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

270

1.63

4.06

4.3

4.7

2.3

mg/l

0.00

228

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

155

1.85

4.05

1.2

1.1

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.31

4.04

1.0

0.5

0.9

u/ml

0.56

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

868

3841

1.16

4.02

2.4

2.5

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.67

4.02

1.0

0.0

0.1

u/ml

0.54

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

220

1.70

4.01

1.3

1.4

1.2

1.7

ml/s/173m2

0.72

152

(3013336) Amino acids [Identifier] in Serum or Plasma

120

1.96

3.95

2.2

2.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

340

1380

1.26

3.89

37.1

36.9

7.5

7.3

ug/l

0.63

310

1272

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.83

3.89

1.0

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

203

1.72

3.88

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

100

331

1.55

3.83

2.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

104

348

1.53

3.80

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

113

386

1.50

3.77

1.5

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

348

1424

1.25

3.74

1.9

2.0

3.4

3.8

ug/l

0.37

293

1266

(3047189) Immunofixation for 24 hour Urine

276

1098

1.29

3.73

1.5

1.9

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

157

573

1.40

3.73

1.4

24.9

22.0

0.59

129

467

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

809

3585

1.16

3.72

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

110

375

1.50

3.71

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

112

385

1.49

3.64

8.1

7.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.98

3.62

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

154

1.80

3.61

4.9

5.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

124

437

1.45

3.57

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

248

1.61

3.56

1.0

0.3

1.7

u/ml

1.89

169

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

280

1124

1.28

3.55

2.4

139.4

155.4

nmol/l

1.44

248

963

(3033942) Copper [Moles/time] in 24 hour Urine

129

1.87

3.53

1.4

1.2

1.9

0.6

umol/24h

0.69

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

300

1216

1.27

3.52

2.5

2.8

117.8

154.3

au/ml

0.72

153

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

376

1565

1.23

3.50

1.8

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

500

2142

1.20

3.48

1.2

1.3

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.46

3.48

1.3

95.2

35.0

e6/l

0.67

(37019676) Renin [Units/volume] in Plasma --supine

2.46

3.48

1.0

1.2

24.7

39.8

mu/l

0.37

(3032352) Blasts [#/volume] in Cerebral spinal fluid

294

1.55

3.48

2.0

3.0

—

(3032641) Amino acids panel - Urine

2.51

3.46

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

169

635

1.36

3.42

9.6

8.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

278

1122

1.27

3.40

2.7

2.9

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

165

1.74

3.39

1.1

1.2

—

470.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

118

417

1.45

3.38

1.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.00

3.36

2.2

2.7

4.3

mmol/l

0.06

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

106

1.93

3.34

2.1

1.5

—

(3002619) Bacteria identified in Specimen by Culture

155

577

1.38

3.33

1.3

1.2

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

110

1.91

3.31

1.7

1.5

0.3

0.2

u/l

0.23

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

134

487

1.41

3.31

2.4

2.7

53.7

44.5

mg/l

0.17

(3010375) cycloSPORINE [Mass/volume] in Blood

321

1323

1.24

3.30

27.1

27.5

121.3

119.0

ug/l

0.22

259

1112

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

108

378

1.46

3.26

2.4

1.9

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

251

1.57

3.22

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

323

1337

1.24

3.20

3.2

3.3

7.9

8.2

mg/l

0.31

259

1075

(3042733) HLA Ab [Presence] in Serum

258

1041

1.27

3.19

4.8

4.9

—

(3035933) Granulocytes/100 leukocytes in Blood

233

930

1.28

3.14

1.4

1.8

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

116

1.86

3.14

1.0

0.1

u/ml

0.09

(3025577) Chromium [Mass/volume] in Blood

334

1393

1.23

3.10

2.0

2.3

2.4

ug/l

0.03

263

1188

(40768800) Prostate Pathology biopsy report

866

5018

0.88

3.09

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

132

1.79

3.07

1.2

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

142

530

1.37

3.04

2.2

2.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

121

440

1.41

3.02

1.1

4.1

7.4

pmol/l

0.36

(3019832) Treponema pallidum Ab [Presence] in Serum

8275

40839

1.04

2.99

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

147

554

1.36

2.98

10.1

8.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

5.86

2.96

1.0

21.3

48.6

umol/l

—

(3020618) Glucose [Moles/volume] in Synovial fluid

2.00

2.96

1.0

5.4

5.0

mmol/l

0.21

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.05

2.96

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

290

1.50

2.94

1.3

466.7

84.8

u/l

0.49

209

(3016273) Islet cell 512 Ab [Units/volume] in Serum

249

1.54

2.93

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.08

2.87

1.0

1.3

—

(3025130) Human papilloma virus identified in Specimen

1022

4689

1.12

2.87

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

740

3331

1.14

2.83

1.5

1.4

32.8

33.2

g/l

0.33

657

2986

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.10

2.82

1.2

—

(3045142) Bone marrow Pathology biopsy report

644

2874

1.15

2.80

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1786

9918

0.92

2.80

1.8

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.11

2.78

1.9

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

249

1021

1.25

2.75

1.7

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.03

2.72

1.0

1.3

287.6

254.9

nmol/l

0.34

(3024932) HLA-DR beta [Type]

251

1032

1.25

2.71

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

165

1.65

2.71

1.0

0.7

11.6

u/ml

0.48

(3012898) Urea [Moles/volume] in Urine

275

1.49

2.70

1.4

1.7

186.2

157.8

mmol/l

1.01

247

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

104

1.82

2.67

1.1

2.0

1.0

u/field

0.57

(3019768) Coxiella burnetii Ab [Presence] in Serum

162

1.65

2.66

1.3

1.1

—

(3024471) HLA-A [Type]

256

1058

1.24

2.65

1.0

—

(4281824)

529

3128

0.87

2.63

1.2

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

199

1.57

2.61

1.1

2.2

1.5

u/ml

0.25

145

(3023199) Leukocytes [#/volume] in Pleural fluid

670

3024

1.14

2.51

1.5

2697.6

3388.7

e6/l

0.54

511

2145

(44806420)

166

656

1.30

2.50

2.2

2.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

181

1.59

2.50

1.3

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

181

1.59

2.50

2.8

2.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

547

2440

1.15

2.45

1.6

1.8

—

(3023383) Lactate [Moles/volume] in Pleural fluid

183

736

1.27

2.42

1.3

3.8

3.5

mmol/l

0.55

163

675

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

149

584

1.31

2.40

2.1

2.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

147

1.64

2.40

1.4

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

116

438

1.36

2.40

1.3

1.2

1.6

1.7

mmol/l

0.35

272

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

360

1.40

2.39

1.6

1.7

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

356

1.40

2.38

3.0

2.6

59.8

75.6

pmol/l

0.51

302

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

288

1.44

2.36

1.4

68.5

72.4

0.48

234

(21494434) Karyotype in Bone marrow

497

2211

1.15

2.33

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.09

2.32

4.9

5.4

0.3

0.2

mmol/l

1.13

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

202

1.52

2.28

1.3

1.2

102.5

112.8

ug/l

0.23

121

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.11

2.27

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

505

2256

1.15

2.25

1.3

330.6

510.8

u/l

4.02

467

2136

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

295

1262

1.20

2.24

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

102

383

1.37

2.21

2.2

2.3

4.3

3.5

ug/l

0.47

136

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

184

1.53

2.17

3.6

4.8

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.20

2.15

1.0

0.1

0.3

u/ml

0.78

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

197

1.51

2.14

1.8

3.3

25.8

421.0

pmol/l

0.62

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.91

2.12

3.8

1.6

1714.4

1647.4

umol/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

603

2741

1.13

2.09

1.5

76805.4

47698.8

e6/l

1.22

383

1603

(3048879) Bone marrow aspiration report

175

715

1.25

2.09

1.8

1.9

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.03

2.09

1.7

1.4

1.8

2.3

mmol/24h

0.92

(3013293) Extractable nuclear Ab [Presence] in Serum

113

437

1.33

2.05

1.5

1.7

—

(3013931) Oligosaccharides [Presence] in Urine

3.42

2.00

1.0

1.1

—

(36303858) Crystals [Presence] in Urine

2.18

2.00

1.1

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

111

1.66

1.99

1.3

1.1

u/field

0.15

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

304

1322

1.18

1.97

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1455

6929

1.08

1.96

1.4

109.1

128.9

pmol/l

1.06

1410

6755

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

400

1779

1.15

1.95

1.3

14.9

14.1

u/l

0.26

355

1648

(3044416) Complement C4 [Mass/volume] in Pleural fluid

104

1.68

1.94

1.2

0.1

g/l

2.30

(3002621) Streptococcal DNAse B [Units/volume] in Serum

301

1.38

1.92

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

245

1.42

1.91

1.2

1.1

22.7

19.7

u/l

0.44

162

(3022229) Phosphate [Moles/volume] in Urine

228

1.44

1.91

2.2

2.4

19.7

20.7

mmol/l

0.17

201

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.75

1.91

1.0

—

(3020393) Adenovirus Ag [Presence] in Stool

107

416

1.32

1.90

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

102

394

1.33

1.90

1.3

1.4

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.91

1.89

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

128

511

1.28

1.88

3.7

5.1

44.8

57.8

u/l

0.55

193

(3027874) Urate [Moles/volume] in Urine

1.77

1.87

1.0

1.1

1.8

9.9

mmol/l

0.50

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

687

3172

1.11

1.86

1.9

21.3

25.8

ug/l

1.57

672

3108

(3036048) Francisella tularensis Ab [Titer] in Serum

169

699

1.24

1.86

1.2

542.2

491.4

titre

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.05

1.86

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.73

1.85

1.1

242.2

259.2

nmol/l

0.22

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

5.12

1.85

1.0

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

536

3080

0.89

1.83

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

252

1.40

1.82

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

184

1.48

1.82

1.4

278.9

328.2

umol/24h

1.52

184

(3007700) Barley IgE Ab [Units/volume] in Serum

151

1.53

1.80

1.0

0.6

10.1

u/ml

0.49

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

214

1.44

1.80

1.8

1.9

195.3

170.6

ug/g

0.49

185

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

107

420

1.31

1.80

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.26

1.73

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.03

1.72

1.1

111.6

100.3

nmol/24h

0.18

(3006567) Chloride [Moles/time] in 24 hour Urine

2.03

1.72

1.1

1.2

—

(3009883) Potato IgE Ab [Units/volume] in Serum

2.14

1.71

1.0

1.1

0.1

0.5

u/ml

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

104

410

1.30

1.71

9.5

6.8

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

573

2636

1.11

1.70

1.3

1.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

329

0.69

1.67

1.0

—

(40765096) Chromosome analysis panel by Banding

175

739

1.21

1.62

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.92

1.60

1.3

1.1

3.4

2.2

0.64

(3046861) Legionella sp Ag [Presence] in Urine

131

1.53

1.59

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.28

1.58

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

693

3235

1.10

1.57

1.5

1.6

7.9

7.5

mmol/l

3.64

433

1899

(3035611) Eosinophils/100 leukocytes in Synovial fluid

174

1.44

1.54

1.3

1.9

0.9

0.5

0.42

139

(3000285) Sodium [Moles/volume] in Blood

318

1.32

1.54

1.1

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

124

1.53

1.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

350

1.30

1.52

1.9

1.7

1.8

1.7

mg/l

0.19

291

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.69

1.51

1.0

1.1

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.60

1.50

1.0

0.0

0.2

u/ml

1.01

(42870560) Thyrotropin [Units/volume] in Cord blood

399

0.73

1.50

1.0

9.1

8.8

mu/l

0.17

330

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1105

5273

1.07

1.50

2.9

3.5

362.7

869.6

u/ml

1.77

1014

4774

(40768806) Pleura Pathology biopsy report

562

2605

1.11

1.49

1.5

—

(3001729) Color of Synovial fluid

206

1.39

1.47

1.3

1.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

151

636

1.22

1.47

1.6

1.3

14.6

13.2

g/l

0.88

113

473

(3042628) Porphyrins [Moles/volume] in Urine

3.07

1.46

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.71

1.46

1.0

0.1

0.3

u/ml

0.58

(40768441) Liver Pathology biopsy report

470

2161

1.12

1.46

1.4

—

(4133840)

201

871

1.18

1.45

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

264

1558

0.87

1.44

5.3

6.2

1134.6

3016.2

u/ml

0.46

332

(3032868) Hemoglobin electrophoresis panel in Blood

282

1.33

1.43

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

233

1385

0.86

1.41

1.1

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.58

1.40

1.0

0.2

u/ml

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

361

1.28

1.36

1.3

1.1

1.5

mmol/l

0.50

234

(3045788) Cell count panel - Pleural fluid

507

2353

1.10

1.34

1.6

1.5

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

338

0.73

1.34

1.0

3.0

3.6

kpa

1.81

290

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.62

1.34

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

2.02

1.33

1.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

144

883

0.84

1.30

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

121

1.48

1.30

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

355

1.27

1.29

2.3

2.6

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

261

1.32

1.27

2.4

3.1

—

(40768446) Kidney Pathology biopsy report

276

1241

1.14

1.27

1.7

1.8

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.78

1.25

1.4

1.3

0.7

0.6

u/field

—

(40762887) Creatinine [Moles/volume] in Blood

1.78

1.25

1.1

1.2

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.96

1.24

1.2

1.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.96

1.24

1.2

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

170

1.39

1.22

1.2

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

2.28

1.22

1.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.98

1.19

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.98

1.19

1.4

1.1

—

(3049242) von Willebrand panel - Platelet poor plasma

1.56

1.18

1.3

1.7

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

107

1.48

1.18

1.1

1.0

0.0

0.1

u/ml

1.23

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

1.58

1.18

5.3

5.9

1.0

1.5

mg/l

0.95

(3011325) HIV 1+2 Ab [Presence] in Serum

150

1.40

1.17

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

305

1391

1.12

1.16

1.2

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

271

1567

0.89

1.15

1.3

—

(3035880) pH of Pleural fluid

296

1351

1.12

1.3

—

(3006598) pH of Arterial cord blood

344

0.76

1.12

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

249

1.30

1.11

1.4

1.2

170.1

396.5

mg/24h

0.62

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5509

27522

1.03

1.11

3.4

4.2

18.9

27.0

ug/l

1.12

4316

21953

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

196

871

1.15

1.11

1.4

62.3

0.00

158

714

(3012441) Differential panel - Pleural fluid

556

2622

1.09

1.11

1.5

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

218

1.32

1.10

1.9

2.1

67.7

57.2

1.19

136

(3022475) Manganese [Moles/volume] in Blood

187

1.34

1.10

1.2

1.3

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

343

0.76

1.10

1.0

7.1

7.3

kpa

0.32

297

(3005082) Progesterone [Moles/volume] in Serum or Plasma

398

2242

0.91

1.07

1.3

1.4

28.7

32.1

nmol/l

1.81

364

2071

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

136

589

1.18

1.07

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

230

0.71

1.07

1.1

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

242

1.29

1.06

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

127

1.41

1.06

1.2

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

1.71

1.06

1.1

1.0

29.6

38.4

iu/ml

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

1.62

1.05

1.1

1.0

2.8

0.6

u/ml

0.37

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.68

1.05

1.4

1.3

—

(3014891) Appearance of Pleural fluid

352

1.24

1.05

1.7

1.6

—

(3004959) Base excess in Arterial cord blood by calculation

340

0.77

1.04

1.0

-3.0

-2.2

mmol/l

0.23

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.80

1.01

1.1

1.0

1349.2

2122.7

titre

0.88

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

2.56

1.00

4.8

5.7

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.88

0.97

1.0

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.36

0.96

1.0

1.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

238

1.27

0.93

1.1

42.0

22.6

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

238

1.27

0.93

1.1

22.0

31.9

u/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

340

1585

1.10

0.92

1.2

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

382

1.21

0.91

1.8

3.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

2.20

0.91

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

2.20

0.91

1.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.20

0.91

1.0

1.1

20.8

14.1

umol/l

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.20

0.91

1.2

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

271

1.25

0.91

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

244

1.26

0.90

1.3

1.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

137

1.35

0.87

3.0

3.5

0.0

estimate

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.54

0.84

1.2

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

174

1.30

0.83

1.8

2.1

8.5

19.3

2.90

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.71

0.82

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.71

0.82

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.71

0.82

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.71

0.82

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.71

0.82

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.71

0.82

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

285

1328

1.10

0.81

1.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

193

1.27

0.81

6.0

5.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1056

5675

0.95

0.81

1.3

3.6

3.8

ug/l

0.24

962

5168

(40768793) Breast Pathology biopsy report

1224

6554

0.96

0.80

1.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

146

0.70

0.78

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

185

1.27

0.78

1.0

1.1

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.45

0.78

1.2

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.55

0.77

1.0

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

105

1.37

0.76

1.0

0.1

0.3

u/ml

1.25

(3021162) Amylase [Enzymatic activity/volume] in Specimen

424

1.17

0.76

3.6

2.6

1463.5

1917.8

u/l

0.26

383

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.71

0.75

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

2.13

0.75

1.2

4.9

139.8

mmol/l

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.13

0.75

1.2

1.0

20.5

36.1

nmol/24h

—

(36304079) Mucus [Presence] in Urine sediment

2.13

0.75

1.0

1.1

—

(3008896) Cortisol [Moles/volume] in Urine

2.13

0.75

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

257

1.22

0.71

1.2

1.4

6.6

7.1

u/ml

0.03

217

(3039443) Prostate specific Ag panel - Serum or Plasma

1032

5057

1.05

0.71

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

305

1.19

0.69

2.8

3.2

1.4

1.3

mg/l

0.07

215

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.39

0.69

3.5

3.6

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

329

1.18

0.68

1.4

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.37

0.67

1.1

1.2

2575.1

3780.7

ng/l

0.40

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.40

0.66

11.6

7.4

—

(3045177) Copper [Moles/volume] in Urine

1.53

0.66

1.0

1.1

0.2

0.5

umol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

148

676

1.12

0.65

1.3

289.5

253.7

ug/l

0.07

369

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.64

0.63

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.48

0.62

1.0

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

385

1.16

0.62

4.6

5.5

53.2

196.8

g/mol

0.58

353

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

201

1.22

0.62

2.4

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

1.42

0.62

10.9

7.9

45.6

45.0

—

(3007147) Virus identified in Stool by Electron microscopy

1.81

0.60

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

221

1.21

0.59

2.9

2.3

275.3

427.2

umol/l

0.89

216

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.54

0.59

1.6

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.57

0.58

1.1

132.8

141.2

mmol/24h

0.24

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.62

0.55

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.49

0.54

2.7

2.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

500

2699

0.95

0.53

3.6

3.8

40.3

51.4

u/ml

0.75

492

2665

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.52

0.52

2.0

2.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

221

1.18

0.50

1.1

27.5

15.8

iu/ml

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.56

0.50

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

142

1.23

0.48

1.0

1.1

—

(3009992) Blasts/100 cells in Bone marrow

1.49

0.48

2.0

1.7

20.7

16.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1851

9719

0.98

0.48

3.0

3.6

2147.0

1815.1

u/ml

0.08

1571

8362

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

453

2206

1.05

0.47

1.6

2.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

357

1.13

0.46

1.3

1.4

9.5

12.1

0.53

183

(3000919) Neutrophils/100 leukocytes in Pleural fluid

143

669

1.10

0.46

1.4

21.9

22.1

0.04

128

607

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

176

1.19

0.45

1.1

1.0

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.34

0.45

1.0

1.1

0.0

0.2

g/l

—

(3029612) Listeria sp Ab [Titer] in Serum

1.32

0.44

1.4

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

322

1745

0.95

0.43

1.6

1.4

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.43

0.0

1.0

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.43

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

535

0.90

0.43

1.3

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

123

690

0.91

0.42

1.2

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

438

1.11

0.42

1.3

—

(46235479) Bilirubin fractions panel [Moles/volume] - Serum or Plasma

0.00

0.42

0.0

1.3

—

88.8

—

(44786800) Granulocytes/100 leukocytes in Body fluid

303

1.13

0.41

1.3

23.0

23.9

0.08

236

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.30

0.40

1.6

1.3

144.0

120.9

ug/l

0.15

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

100

565

0.91

0.40

1.6

1.9

2.2

3.6

ug/l

0.69

348

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

146

1.19

0.39

1.5

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

377

1.11

0.39

9.3

10.2

0.4

umol/l

0.16

346

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.41

0.39

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

247

1.14

0.38

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

344

1.12

0.38

7.3

7.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

114

1.21

0.37

1.0

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

229

1.14

0.36

1.1

1.2

17.3

17.1

g/l

0.06

206

(3001218) Citrate [Mass/time] in 24 hour Urine

1.37

0.35

1.4

—

(3013762) Body weight Measured

131

0.82

0.33

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

164

0.84

0.33

3.3

4.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

158

0.84

0.32

3.4

4.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

280

1367

1.05

0.32

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

280

1368

1.05

0.31

1.4

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

438

1.09

0.30

1.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.28

0.30

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

204

1.13

0.29

1.0

1.1

—

(3025966) Peach IgE Ab [Units/volume] in Serum

1.32

0.29

1.1

1.0

2.4

4.3

u/ml

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

122

584

1.07

0.28

1.5

1.3

25.3

29.1

g/l

0.69

100

441

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.19

0.28

1.0

0.1

1.1

u/ml

0.72

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.24

0.28

1.1

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.67

0.27

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.19

0.26

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

154

746

1.06

0.26

1.4

4.2

2.5

1.07

129

626

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.21

0.25

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

181

0.88

0.25

1.0

1.3

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.35

0.24

1.0

—

(3002853) Influenza virus B Ab [Titer] in Serum

1.28

0.23

1.0

—

(4212803)

223

1.10

0.23

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

111

1.15

0.23

1.0

0.1

0.5

u/ml

1.27

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.21

0.22

6.2

5.1

5.4

6.9

mg/l

0.26

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

423

2105

1.03

0.22

1.3

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

194

1.11

0.22

1.2

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

141

0.87

0.22

1.0

1.1

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.1

—

153.1

—

(3033799) Differential panel - Peritoneal fluid

165

810

1.04

0.19

1.9

1.8

—

(3003157) Bacteria [#/volume] in Mother's milk

0.84

0.18

2.8

7.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.14

0.17

4.2

6.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

391

1.06

0.17

1.3

1.9

6.7

7.3

mmol/l

0.69

138

(4038314)

292

0.93

0.17

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

198

1.09

0.16

1.0

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

278

1.07

0.16

3.8

3.0

13.4

10.1

0.44

(40768795) Lymph node Pathology biopsy report

543

2835

0.98

0.15

1.2

—

(3034614) HLA Ag [Interpretation]

1.15

0.15

1.1

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

219

1.08

0.15

1.3

1.1

9.5

mg/l

0.01

202

(3023487) Leukocytes [#/volume] in Peritoneal fluid

189

938

1.03

0.14

2.4

1.8

7492.6

1611.4

e6/l

0.70

140

611

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

155

1.09

0.14

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

145

770

0.96

0.14

2.5

137.5

105.8

ng/l

0.52

441

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

390

2040

0.98

0.14

1.3

1.5

g/l

1.46

119

(3007919) Fasciola sp Ab [Titer] in Serum

1.17

0.14

1.0

1.1

—

(3025315) Body weight

250

1.07

0.13

4.2

4.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

146

723

1.03

0.13

1.7

1.9

—

(3044007) Cell count panel - Peritoneal fluid

144

763

0.97

0.13

2.2

1.8

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

114

0.90

0.13

1.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

381

1.05

0.13

2.9

3.2

24.1

23.2

mg/l

0.19

365

(3022670) pH of Venous cord blood

117

1.09

0.12

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

157

1.08

0.11

1.3

114.7

1242.8

u/l

1.27

137

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

232

1.06

0.11

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.12

0.11

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

143

1.07

0.10

17.2

10.5

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.11

0.10

1.8

1.4

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.15

0.09

1.0

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

442

1.03

0.08

1.3

1.1

20.8

20.2

mmol/l

0.69

391

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

278

0.96

0.08

1.9

2.5

3.3

3.2

mg/l

0.08

267

(3040794) Aluminum [Moles/volume] in Urine

0.85

0.07

1.4

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

810

4119

1.01

0.07

2.6

2.9

548.9

734.9

u/ml

0.18

776

3900

(40765089) Chromosome analysis panel - Blood by G-banded

252

1308

0.99

0.06

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

222

1.04

0.05

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

166

837

1.02

0.05

2.4

1.7

12975.2

10323.7

e6/l

0.19

431

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.08

0.05

1.1

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

457

1.02

0.04

4.9

5.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

119

600

1.02

0.04

5.2

6.1

—

(40763590) HLA-DQ beta [Type]

117

1.05

0.04

1.0

—

(3003577) Lead [Moles/volume] in Blood

250

1.02

0.03

1.4

0.2

umol/l

0.17

(3013945) Hepatitis B virus e Ab [Presence] in Serum

194

0.98

0.01

1.2

1.5

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.93

0.01

5.1

3.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

163

0.97

0.01

3.9

3.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

127

0.97

0.01

11.6

9.2

—

(46236302) HLA-C [Type] by High resolution typing

119

1.03

0.01

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

375

1.01

0.01

3.0

3.3

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

1.01

0.00

1.0

1.1

34.7

33.2

0.08

(40760409) HLA-A [Type] by High resolution

118

1.00

0.00

1.0

—

(40760410) HLA-B [Type] by High resolution

118

1.00

0.00

1.0

—

(3013862) HLA-DP [Type]

120

0.98

0.00

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

230

1181

1.00

0.00

2.8

3.0

—

(40758358) Immune stain study

122

1.01

0.00

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.97

0.00

2.2

2.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

166

0.99

0.00

12.2

9.7

100.7

224.5

e6/l

1.07

119

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

309

0.99

0.00

1.2

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_EPIPAROX and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_EPIPAROX	1.449 [1.34, 1.57]	< 0.001
Birth year	0.992 [0.99, 1.0]	0.044

During the follow-up period (1.1.1998 — 31.12.2019), 62646 out of 361208 females with G6_EPIPAROX died.

Males

Parameter	HR [95% CI]	p-value
G6_EPIPAROX	1.57 [1.44, 1.71]	< 0.001
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 67429 out of 331774 males with G6_EPIPAROX died.

Mortality risk

Mortality risk for people of age

years, who have G6_EPIPAROX.

N-year risk	Females	Males
1	0.098%	0.197%
5	0.654%	1.161%
10	1.779%	3.214%
15	3.239%	6.121%
20	5.685%	10.154%

Relationships between endpoints

↥

Index endpoint: G6_EPIPAROX – Episodal and paroxysmal disorders

GWS hits: 29

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Episodal and paroxysmal disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints